<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Surg</journal-id><journal-id journal-id-type="iso-abbrev">Int J Surg</journal-id><journal-id journal-id-type="pmc-domain-id">2035</journal-id><journal-id journal-id-type="pmc-domain">lwwopen</journal-id><journal-id journal-id-type="publisher-id">JS9</journal-id><journal-title-group><journal-title>International Journal of Surgery (London, England)</journal-title></journal-title-group><issn pub-type="ppub">1743-9191</issn><issn pub-type="epub">1743-9159</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Lippincott Open Access</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12430949</article-id><article-id pub-id-type="pmcid-ver">PMC12430949.1</article-id><article-id pub-id-type="pmcaid">12430949</article-id><article-id pub-id-type="pmcaiid">12430949</article-id><article-id pub-id-type="pmid">40557503</article-id><article-id pub-id-type="doi">10.1097/JS9.0000000000002722</article-id><article-id pub-id-type="publisher-id">IJS-D-24-07218</article-id><article-version-alternatives><article-version article-version-type="pmc-version">1</article-version><article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" article-version-type="Version of Record">3</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Global research trend of graphene application in breast cancer: a bibliometric analysis</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Zhang</surname><given-names initials="M">Mengdi</given-names></name><degrees>PhD</degrees><xref rid="aff1" ref-type="aff">
<sup>a</sup>
</xref><email>z17864190303@163.com</email></contrib><contrib contrib-type="author"><name name-style="western"><surname>Pu</surname><given-names initials="D">Dongqing</given-names></name><degrees>PhD</degrees><xref rid="aff2" ref-type="aff">
<sup>b</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yu</surname><given-names initials="M">Minmin</given-names></name><degrees>MD</degrees><xref rid="aff3" ref-type="aff">
<sup>c</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shi</surname><given-names initials="G">Guangxi</given-names></name><degrees>MD</degrees><xref rid="aff2" ref-type="aff">
<sup>b</sup>
</xref><email>doctorsgx@163.com</email></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Li</surname><given-names initials="J">Jingwei</given-names></name><degrees>PhD</degrees><xref rid="aff2" ref-type="aff">
<sup>b</sup>
</xref><xref rid="COR0001" ref-type="corresp">*</xref></contrib><aff id="aff1"><label>a</label>First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, China</aff><aff id="aff2"><label>b</label>Department of Thyroid and Breast Diagnosis and Treatment Center, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China</aff><aff id="aff3"><label>c</label>Department of Pathology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China</aff></contrib-group><author-notes><corresp id="COR0001"><label>*</label>Corresponding author. Address: Department of Thyroid and Breast Surgery, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan City 250014, China. Tel.: +86 18866257028. E-mail: <email>71000395@sdutcm.edu.cn</email> (J. Li).</corresp></author-notes><pub-date pub-type="collection"><month>9</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>25</day><month>6</month><year>2025</year></pub-date><volume>111</volume><issue>9</issue><issue-id pub-id-type="pmc-issue-id">496813</issue-id><fpage>6305</fpage><lpage>6317</lpage><history><date date-type="received"><day>20</day><month>12</month><year>2024</year></date><date date-type="accepted"><day>30</day><month>5</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>12</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>13</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-13 17:25:36.317"><day>13</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2025 The Author(s). Published by Wolters Kluwer Health, Inc.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-Non Commercial-No Derivatives License 4.0</ext-link> (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="js9-111-6305.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="js9-111-6305.pdf"/><abstract><p>Breast cancer (BC) is the most common malignancy among women, and its incidence has steadily increased annually. Traditional diagnostic and therapeutic approaches have limitations, prompting an urgent need to explore innovative strategies. Graphene possesses notable advantages, including strong biocompatibility, excellent biosafety, and effective active targeting, providing promising new avenues for BC treatment. This study aims to evaluate the current status and emerging trends of graphene applications in BC using bibliometric methods. Publications related to graphene and BC were retrieved from the Web of Science core collection, screened according to inclusion criteria, and analyzed using CiteSpace and VOSviewer for data analysis and visualization. A total of 1395 publications were included in this analysis. From 2010 to 2024, the number of publications increased significantly. China and Iran dominate research output in this field, with China contributing the highest number of publications, total citations, average citations per paper, and H-index. The Chinese Academy of Sciences and Duarte de Melo-Diogo are the most influential institution and author, respectively, while <italic toggle="yes">Biosensors and Bioelectronics</italic> are the most productive journal. Recent research hotspots include the use of graphene in photothermal therapy and biosensing for BC. This bibliometric analysis comprehensively summarizes the current application status and research hotspots of graphene in BC and identifies future application trends. These findings provide valuable insights into the utilization and development directions of graphene in BC.</p></abstract><kwd-group><kwd>bibliometric analysis</kwd><kwd>breast cancer</kwd><kwd>graphene</kwd><kwd>research trend</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>SDC</meta-name><meta-value>T</meta-value></custom-meta><custom-meta><meta-name>OPEN-ACCESS</meta-name><meta-value>TRUE</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Breast cancer (BC) is the most common malignancy among women globally<sup>[<xref rid="R1" ref-type="bibr">1</xref>]</sup>. Traditional diagnostic and therapeutic methods face several challenges, including limited accuracy, significant toxic side effects, and drug resistance<sup>[<xref rid="R2" ref-type="bibr">2</xref>]</sup>. Due to its unique two-dimensional nanostructure, high biocompatibility, and potential for multifunctional modification, graphene offers innovative opportunities for BC diagnosis and treatment<sup>[<xref rid="R3" ref-type="bibr">3</xref>]</sup>. Graphene and its derivatives can function as targeted drug carriers, enable tumor ablation through photothermal effects, or facilitate early diagnosis via highly sensitive biosensors<sup>[<xref rid="R4" ref-type="bibr">4</xref>]</sup>. Additionally, they exhibit low toxicity owing to their carbon-based structure<sup>[<xref rid="R5" ref-type="bibr">5</xref>]</sup>.<boxed-text id="UBT0001" position="float" orientation="portrait"><sec><title>HIGHLIGHTS</title><p><list list-type="bullet"><list-item><p>This study puts forward the first bibliometric analysis of graphene materials in the field of diagnosis and treatment of breast cancer.</p></list-item><list-item><p>China has made great contributions in this field. The Chinese Academy of Sciences is the most influential institution, <italic toggle="yes">Biosensors and Bioelectronics</italic> is the most cited periodical.</p></list-item><list-item><p>The research trend of graphene in the field of breast cancer is gradually shifting from drug delivery to more abundant applications, such as electrochemical sensor and photothermal therapy.</p></list-item><list-item><p>Graphene, with its unique properties and chemical structure, will overcome the limitations of existing methods and help the diagnosis and treatment of breast cancer enter a new stage.</p></list-item></list></p></sec></boxed-text></p><p>Despite notable research progress, the field lacks comprehensive summaries and systematic reviews of the global research landscape, evolving hotspots, and interdisciplinary collaboration mechanisms. Under the premise of following the TITAN Guidelines 2025 governing declaration and use of artificial intelligence (AI)<sup>[<xref rid="R6" ref-type="bibr">6</xref>]</sup>, this approach addresses the qualitative limitations of traditional reviews by integrating relevant literature and utilizing bibliometric tools. It also bridges the cognitive gap between macro-level trends and micro-level technologies, providing researchers with visualized references for effective resource allocation. This study adopts a data-driven methodology to comprehensively analyze the current research state, laying the groundwork for optimizing research directions, avoiding redundant innovations, and promoting clinical translation.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Data source and search strategy</title><p>Data were obtained from the Web of Science Core Collection (WOSCC)<sup>[<xref rid="R7" ref-type="bibr">7</xref>]</sup>. The search strategy was: TS&#160;=&#160;(Breast OR Mammary) AND TS&#160;=&#160;(cancer OR tumor OR carcinoma OR neoplasm OR tumorous OR neoplastic) AND TS&#160;=&#160;(graphene). The search term &#8220;graphene&#8221; retrieved all relevant literature, including graphene oxide, reduced graphene oxide, graphene quantum dots (GQDs), and graphene&#8211;gold-based nanocomposites. The search was limited to articles and reviews published in English up to November 20, 2024.</p></sec><sec><title>Data extraction and analysis</title><p>Information including authors, institutions, countries, journals, publication years, and citations was extracted from the final literature set for comprehensive evaluation.</p><p>VOSviewer (version 1.6.19)<sup>[<xref rid="R8" ref-type="bibr">8</xref>]</sup> was employed for country, journal, keyword, and author co-occurrence analysis. Keywords were grouped into clusters based on association strength and direction, represented by distinct colors and temporal progression.</p><p>CiteSpace (version 6.3.R1)<sup>[<xref rid="R9" ref-type="bibr">9</xref>]</sup> was utilized for reference burst detection, keyword burst and clustering, institution burst and co-occurrence, and author burst analysis. Parameters included a time interval of 1 year, g-index (<italic toggle="yes">k</italic> =&#160;17), link retaining factor (LRF&#160;=&#160;3.0), maximum links per node (L/N&#160;=&#160;10), look-back years (LBY&#160;=&#160;5), and <italic toggle="yes">e</italic> =&#160;1.0. All other settings remained at default.</p></sec></sec><sec sec-type="results"><title>Results</title><sec><title>Timeline distribution of publications</title><p>A total of 1395 publications were identified as &#8220;all records and references&#8221; (Fig. <xref rid="F1" ref-type="fig">1</xref>).
<fig position="float" id="F1" orientation="portrait"><label>Figure 1.</label><caption><p>Flowchart of publications screening.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="js9-111-6305-g001.jpg"/></fig>
</p><sec><title>Data standardization</title><p>Table <xref rid="T1" ref-type="table">1</xref> shows that graphene research in BC began in 2010. Between 2010 and 2024, publication numbers and citations steadily increased, peaking in 2022 (188 publications). Citations reached their highest level (8126 times) in 2017, and the highest H-index (55) occurred in 2018.
<table-wrap position="float" id="T1" orientation="portrait"><label>Table 1</label><caption><p>Timeline distribution of publications and citations</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Year</th><th align="left" rowspan="1" colspan="1">TP</th><th align="left" rowspan="1" colspan="1">TC</th><th align="left" rowspan="1" colspan="1">ACPP</th><th align="left" rowspan="1" colspan="1">H-Index</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">2010</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1500</td><td align="center" rowspan="1" colspan="1">1500</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">2011</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">1078</td><td align="center" rowspan="1" colspan="1">179.67</td><td align="center" rowspan="1" colspan="1">6</td></tr><tr><td align="left" rowspan="1" colspan="1">2012</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">1558</td><td align="center" rowspan="1" colspan="1">111.29</td><td align="center" rowspan="1" colspan="1">14</td></tr><tr><td align="left" rowspan="1" colspan="1">2013</td><td align="center" rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">2929</td><td align="center" rowspan="1" colspan="1">133.14</td><td align="center" rowspan="1" colspan="1">21</td></tr><tr><td align="left" rowspan="1" colspan="1">2014</td><td align="center" rowspan="1" colspan="1">43</td><td align="center" rowspan="1" colspan="1">2681</td><td align="center" rowspan="1" colspan="1">62.31</td><td align="center" rowspan="1" colspan="1">31</td></tr><tr><td align="left" rowspan="1" colspan="1">2015</td><td align="center" rowspan="1" colspan="1">54</td><td align="center" rowspan="1" colspan="1">3550</td><td align="center" rowspan="1" colspan="1">65.74</td><td align="center" rowspan="1" colspan="1">34</td></tr><tr><td align="left" rowspan="1" colspan="1">2016</td><td align="center" rowspan="1" colspan="1">74</td><td align="center" rowspan="1" colspan="1">4465</td><td align="center" rowspan="1" colspan="1">60.34</td><td align="center" rowspan="1" colspan="1">39</td></tr><tr><td align="left" rowspan="1" colspan="1">2017</td><td align="center" rowspan="1" colspan="1">119</td><td align="center" rowspan="1" colspan="1">8126</td><td align="center" rowspan="1" colspan="1">68.29</td><td align="center" rowspan="1" colspan="1">50</td></tr><tr><td align="left" rowspan="1" colspan="1">2018</td><td align="center" rowspan="1" colspan="1">154</td><td align="center" rowspan="1" colspan="1">7795</td><td align="center" rowspan="1" colspan="1">50.62</td><td align="center" rowspan="1" colspan="1">55</td></tr><tr><td align="left" rowspan="1" colspan="1">2019</td><td align="center" rowspan="1" colspan="1">121</td><td align="center" rowspan="1" colspan="1">4708</td><td align="center" rowspan="1" colspan="1">38.91</td><td align="center" rowspan="1" colspan="1">42</td></tr><tr><td align="left" rowspan="1" colspan="1">2020</td><td align="center" rowspan="1" colspan="1">167</td><td align="center" rowspan="1" colspan="1">5520</td><td align="center" rowspan="1" colspan="1">33.05</td><td align="center" rowspan="1" colspan="1">43</td></tr><tr><td align="left" rowspan="1" colspan="1">2021</td><td align="center" rowspan="1" colspan="1">178</td><td align="center" rowspan="1" colspan="1">4738</td><td align="center" rowspan="1" colspan="1">26.62</td><td align="center" rowspan="1" colspan="1">38</td></tr><tr><td align="left" rowspan="1" colspan="1">2022</td><td align="center" rowspan="1" colspan="1">188</td><td align="center" rowspan="1" colspan="1">3419</td><td align="center" rowspan="1" colspan="1">18.19</td><td align="center" rowspan="1" colspan="1">32</td></tr><tr><td align="left" rowspan="1" colspan="1">2023</td><td align="center" rowspan="1" colspan="1">157</td><td align="center" rowspan="1" colspan="1">1503</td><td align="center" rowspan="1" colspan="1">9.57</td><td align="center" rowspan="1" colspan="1">19</td></tr><tr><td align="left" rowspan="1" colspan="1">2024</td><td align="center" rowspan="1" colspan="1">121</td><td align="center" rowspan="1" colspan="1">148</td><td align="center" rowspan="1" colspan="1">1.11</td><td align="center" rowspan="1" colspan="1">5</td></tr></tbody></table></table-wrap>
</p></sec></sec><sec><title>Analysis of countries distribution</title><p>This study identified 73 countries, primarily including China, Iran, India, the USA, and South Korea. China had the highest number of publications (544, 39%), total citations (26 790), average citation times per paper (80.05), and H-index (101) (Table <xref rid="T2" ref-type="table">2</xref>).
<table-wrap position="float" id="T2" orientation="portrait"><label>Table 2</label><caption><p>Top 10 countries by publication count</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Country</th><th align="left" rowspan="1" colspan="1">TP</th><th align="left" rowspan="1" colspan="1">TC</th><th align="left" rowspan="1" colspan="1">ACPP</th><th align="left" rowspan="1" colspan="1">H-Index</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">China</td><td align="center" rowspan="1" colspan="1">544</td><td align="center" rowspan="1" colspan="1">26&#160;790</td><td align="center" rowspan="1" colspan="1">80.05</td><td align="center" rowspan="1" colspan="1">101</td></tr><tr><td align="left" rowspan="1" colspan="1">Iran</td><td align="center" rowspan="1" colspan="1">283</td><td align="center" rowspan="1" colspan="1">8013</td><td align="center" rowspan="1" colspan="1">28.31</td><td align="center" rowspan="1" colspan="1">48</td></tr><tr><td align="left" rowspan="1" colspan="1">India</td><td align="center" rowspan="1" colspan="1">220</td><td align="center" rowspan="1" colspan="1">5861</td><td align="center" rowspan="1" colspan="1">26.64</td><td align="center" rowspan="1" colspan="1">44</td></tr><tr><td align="left" rowspan="1" colspan="1">USA</td><td align="center" rowspan="1" colspan="1">161</td><td align="center" rowspan="1" colspan="1">9340</td><td align="center" rowspan="1" colspan="1">58.01</td><td align="center" rowspan="1" colspan="1">49</td></tr><tr><td align="left" rowspan="1" colspan="1">South Korea</td><td align="center" rowspan="1" colspan="1">93</td><td align="center" rowspan="1" colspan="1">3482</td><td align="center" rowspan="1" colspan="1">37.44</td><td align="center" rowspan="1" colspan="1">32</td></tr><tr><td align="left" rowspan="1" colspan="1">Saudi Arabia</td><td align="center" rowspan="1" colspan="1">65</td><td align="center" rowspan="1" colspan="1">1591</td><td align="center" rowspan="1" colspan="1">24.48</td><td align="center" rowspan="1" colspan="1">21</td></tr><tr><td align="left" rowspan="1" colspan="1">England</td><td align="center" rowspan="1" colspan="1">37</td><td align="center" rowspan="1" colspan="1">1179</td><td align="center" rowspan="1" colspan="1">31.86</td><td align="center" rowspan="1" colspan="1">20</td></tr><tr><td align="left" rowspan="1" colspan="1">Turkey</td><td align="center" rowspan="1" colspan="1">37</td><td align="center" rowspan="1" colspan="1">1051</td><td align="center" rowspan="1" colspan="1">28.41</td><td align="center" rowspan="1" colspan="1">21</td></tr><tr><td align="left" rowspan="1" colspan="1">Egypt</td><td align="center" rowspan="1" colspan="1">36</td><td align="center" rowspan="1" colspan="1">890</td><td align="center" rowspan="1" colspan="1">24.71</td><td align="center" rowspan="1" colspan="1">15</td></tr><tr><td align="left" rowspan="1" colspan="1">Italy</td><td align="center" rowspan="1" colspan="1">33</td><td align="center" rowspan="1" colspan="1">998</td><td align="center" rowspan="1" colspan="1">30.24</td><td align="center" rowspan="1" colspan="1">19</td></tr></tbody></table></table-wrap>
</p><p>The publication trends of the top five countries were further analyzed (Fig. <xref rid="F2" ref-type="fig">2</xref>). China initiated graphene research in BC first, followed by the USA and South Korea 1 year later. The publication counts for the top 10 countries demonstrated consistent fluctuations and overall growth.
<fig position="float" id="F2" orientation="portrait"><label>Figure 2.</label><caption><p>Publication trends of the top 10 countries.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="js9-111-6305-g002.jpg"/></fig>
</p><p>To assess international collaboration, a cooperation network was generated (Fig. <xref rid="F3" ref-type="fig">3</xref>). Among the 73 countries, 29 (39.73%) were from Europe, 29 (39.73%) from Asia, 7 (9.59%) from Africa, 3 (4.11%) from South America, 3 (4.11%) from North America, and 3 (4.11%) from Oceania. China and India occupied central positions within the network, demonstrating extensive cooperation with other countries.<fig position="float" id="F3" orientation="portrait"><label>Figure 3.</label><caption><p>Co-authorship network of countries.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="js9-111-6305-g003.jpg"/></fig>
</p></sec><sec><title>Analysis of institutions distribution</title><p>This study identified the 10 most productive and influential institutions in the field of graphene applications in BC (Table <xref rid="T3" ref-type="table">3</xref>).
<table-wrap position="float" id="T3" orientation="portrait"><label>Table 3</label><caption><p>Top 10 institutions by publication count</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Institution</th><th align="left" rowspan="1" colspan="1">Country</th><th align="left" rowspan="1" colspan="1">TP</th><th align="left" rowspan="1" colspan="1">TC</th><th align="left" rowspan="1" colspan="1">ACPP</th><th align="left" rowspan="1" colspan="1">H-Index</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Chinese Academy of Sciences</td><td align="left" rowspan="1" colspan="1">CHINA</td><td align="center" rowspan="1" colspan="1">65</td><td align="center" rowspan="1" colspan="1">5840</td><td align="center" rowspan="1" colspan="1">89.85</td><td align="center" rowspan="1" colspan="1">35</td></tr><tr><td align="left" rowspan="1" colspan="1">Tabriz University of Medical Sciences</td><td align="left" rowspan="1" colspan="1">IRAN</td><td align="center" rowspan="1" colspan="1">57</td><td align="center" rowspan="1" colspan="1">2245</td><td align="center" rowspan="1" colspan="1">39.39</td><td align="center" rowspan="1" colspan="1">29</td></tr><tr><td align="left" rowspan="1" colspan="1">University of Tehran</td><td align="left" rowspan="1" colspan="1">IRAN</td><td align="center" rowspan="1" colspan="1">40</td><td align="center" rowspan="1" colspan="1">1523</td><td align="center" rowspan="1" colspan="1">3.08</td><td align="center" rowspan="1" colspan="1">23</td></tr><tr><td align="left" rowspan="1" colspan="1">Islamic Azad University</td><td align="left" rowspan="1" colspan="1">IRAN</td><td align="center" rowspan="1" colspan="1">38</td><td align="center" rowspan="1" colspan="1">960</td><td align="center" rowspan="1" colspan="1">25.26</td><td align="center" rowspan="1" colspan="1">15</td></tr><tr><td align="left" rowspan="1" colspan="1">Academic Center for Education, Culture, and Research</td><td align="left" rowspan="1" colspan="1">IRAN</td><td align="center" rowspan="1" colspan="1">33</td><td align="center" rowspan="1" colspan="1">824</td><td align="center" rowspan="1" colspan="1">24.97</td><td align="center" rowspan="1" colspan="1">16</td></tr><tr><td align="left" rowspan="1" colspan="1">Indian Institute of Technology System, IIT System</td><td align="left" rowspan="1" colspan="1">INDIA</td><td align="center" rowspan="1" colspan="1">33</td><td align="center" rowspan="1" colspan="1">903</td><td align="center" rowspan="1" colspan="1">27.36</td><td align="center" rowspan="1" colspan="1">16</td></tr><tr><td align="left" rowspan="1" colspan="1">Egyptian Knowledge Bank, EKB</td><td align="left" rowspan="1" colspan="1">Egypt</td><td align="center" rowspan="1" colspan="1">32</td><td align="center" rowspan="1" colspan="1">871</td><td align="center" rowspan="1" colspan="1">27.22</td><td align="center" rowspan="1" colspan="1">15</td></tr><tr><td align="left" rowspan="1" colspan="1">Shanghai Jiao Tong University</td><td align="left" rowspan="1" colspan="1">CHINA</td><td align="center" rowspan="1" colspan="1">29</td><td align="center" rowspan="1" colspan="1">1218</td><td align="center" rowspan="1" colspan="1">42</td><td align="center" rowspan="1" colspan="1">17</td></tr><tr><td align="left" rowspan="1" colspan="1">Council of Scientific and Industrial Research, CSIR India</td><td align="left" rowspan="1" colspan="1">INDIA</td><td align="center" rowspan="1" colspan="1">28</td><td align="center" rowspan="1" colspan="1">622</td><td align="center" rowspan="1" colspan="1">22.21</td><td align="center" rowspan="1" colspan="1">14</td></tr><tr><td align="left" rowspan="1" colspan="1">Tehran University of Medical Sciences</td><td align="left" rowspan="1" colspan="1">IRAN</td><td align="center" rowspan="1" colspan="1">28</td><td align="center" rowspan="1" colspan="1">947</td><td align="center" rowspan="1" colspan="1">33.82</td><td align="center" rowspan="1" colspan="1">17</td></tr></tbody></table></table-wrap>
</p><p>The Chinese Academy of Sciences had the highest productivity (65 publications), followed by Tabriz University of Medical Sciences (57 publications), and University of Tehran (40 publications). In terms of total citations, the Chinese Academy of Sciences ranked first (5840 citations), followed by Tabriz University of Medical Sciences (2245 citations). The Chinese Academy of Sciences also had the highest H-index (35). Among the top 10 institutions, 5 are from Iran, 2 from China, 2 from India, and 1 from Egypt.</p><p>Institutional collaboration was further analyzed. Figure <xref rid="F4" ref-type="fig">4</xref>a shows a collaboration network involving 298 institutions. Figure <xref rid="F4" ref-type="fig">4</xref>b illustrates the 13 institutions with the strongest citation bursts, each with a citation intensity greater than 3. The Chinese Academy of Sciences, appearing in 2010, showed the greatest citation strength (Strength&#160;=&#160;7.6).
<fig position="float" id="F4" orientation="portrait"><label>Figure 4.</label><caption><p>Analysis of institutions distribution. (A) Co-authorship network of institutions. (B) Top 10 institutions with the strongest citation bursts.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="js9-111-6305-g004.jpg"/></fig>
</p></sec><sec><title>Analysis of influential and co-cited journals</title><p>A total of 200 journals published articles related to graphene and BC. The top 10 journals accounted for 22.37% (312 out of 1395) of total publications (Table <xref rid="T4" ref-type="table">4</xref>).
<table-wrap position="float" id="T4" orientation="portrait"><label>Table 4</label><caption><p>Top 10 journals by publication count</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Journal</th><th align="left" rowspan="1" colspan="1">TP</th><th align="left" rowspan="1" colspan="1">TC</th><th align="left" rowspan="1" colspan="1">ACPP</th><th align="left" rowspan="1" colspan="1">H-Index</th><th align="left" rowspan="1" colspan="1">IF (2024)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><italic toggle="yes">Biosensors and Bioelectronics</italic></td><td align="center" rowspan="1" colspan="1">58</td><td align="center" rowspan="1" colspan="1">4219</td><td align="center" rowspan="1" colspan="1">72.74</td><td align="center" rowspan="1" colspan="1">42</td><td align="center" rowspan="1" colspan="1">10.7</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic toggle="yes">ACS Applied Materials Interfaces</italic></td><td align="center" rowspan="1" colspan="1">48</td><td align="center" rowspan="1" colspan="1">3196</td><td align="center" rowspan="1" colspan="1">66.58</td><td align="center" rowspan="1" colspan="1">35</td><td align="center" rowspan="1" colspan="1">8.3</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic toggle="yes">RSC Advances</italic></td><td align="center" rowspan="1" colspan="1">30</td><td align="center" rowspan="1" colspan="1">777</td><td align="center" rowspan="1" colspan="1">25.9</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">3.9</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic toggle="yes">Sensors and Actuators B: Chemical</italic></td><td align="center" rowspan="1" colspan="1">30</td><td align="center" rowspan="1" colspan="1">1649</td><td align="center" rowspan="1" colspan="1">54.97</td><td align="center" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">8</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic toggle="yes">Nanomaterials</italic></td><td align="center" rowspan="1" colspan="1">26</td><td align="center" rowspan="1" colspan="1">685</td><td align="center" rowspan="1" colspan="1">26.35</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">4.4</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic toggle="yes">Journal of Drug Delivery Science and Technology</italic></td><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">490</td><td align="center" rowspan="1" colspan="1">19.6</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">4.5</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic toggle="yes">Microchimica Acta</italic></td><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">689</td><td align="center" rowspan="1" colspan="1">27.56</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">5.3</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic toggle="yes">Analytical Chemistry</italic></td><td align="center" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">1282</td><td align="center" rowspan="1" colspan="1">53.42</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">6.7</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic toggle="yes">Journal of Materials Chemistry B</italic></td><td align="center" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">906</td><td align="center" rowspan="1" colspan="1">39.39</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">6.1</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic toggle="yes">Scientific Reports</italic></td><td align="center" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">668</td><td align="center" rowspan="1" colspan="1">29.04</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">3.8</td></tr></tbody></table></table-wrap>
</p><p><italic toggle="yes">Biosensors and Bioelectronics</italic> ranked highest in total publications, total citations, average citations per publication, H-index, and impact factor (IF). The IFs of the top 10 journals were all &#8805;3.8.</p><p>Larger nodes in the figure indicate a greater number of publications. Lines connecting nodes represent cross-citations between journals, illustrating a positive citation relationship among journals publishing in graphene and BC (Fig. <xref rid="F5" ref-type="fig">5</xref>a). Purple indicates that entered the field earlier, while yellow indicates newly emerged journals in the current year (Fig. <xref rid="F5" ref-type="fig">5</xref>b).
<fig position="float" id="F5" orientation="portrait"><label>Figure 5.</label><caption><p>Citation network of journals.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="js9-111-6305-g005.jpg"/></fig>
</p></sec><sec><title>Analysis of highly cited articles</title><p>Table <xref rid="T5" ref-type="table">5</xref> presents the 10 most cited articles in graphene and BC research. Four articles were cited more than 500 times. The most cited article (1501 citations) was titled &#8220;Functional Graphene Oxide as a Nanocarrier for Controlled Loading and Targeted Delivery of Mixed Anticancer Drugs,&#8221; published by Zhang LM in Small (2010).<table-wrap position="float" id="T5" orientation="portrait"><label>Table 5</label><caption><p>Top 10 most cited articles</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Year</th><th align="left" rowspan="1" colspan="1">First author</th><th align="left" rowspan="1" colspan="1">Title</th><th align="left" rowspan="1" colspan="1">Journal</th><th align="left" rowspan="1" colspan="1">Citations</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">2010</td><td align="left" rowspan="1" colspan="1">Zhang, LM<sup>[<xref rid="R10" ref-type="bibr">10</xref>]</sup></td><td align="left" rowspan="1" colspan="1">Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs</td><td align="left" rowspan="1" colspan="1"><italic toggle="yes">Small</italic></td><td align="center" rowspan="1" colspan="1">1501</td></tr><tr><td align="left" rowspan="1" colspan="1">2017</td><td align="left" rowspan="1" colspan="1">Tao, W<sup>[<xref rid="R11" ref-type="bibr">11</xref>]</sup></td><td align="left" rowspan="1" colspan="1">Black phosphorus nanosheets as a robust delivery platform for cancer theranostics</td><td align="left" rowspan="1" colspan="1"><italic toggle="yes">Advanced Materials</italic></td><td align="center" rowspan="1" colspan="1">733</td></tr><tr><td align="left" rowspan="1" colspan="1">2016</td><td align="left" rowspan="1" colspan="1">Ou, LL<sup>[<xref rid="R12" ref-type="bibr">12</xref>]</sup></td><td align="left" rowspan="1" colspan="1">Toxicity of graphene-family nanoparticles: a general review of the origins and mechanisms</td><td align="left" rowspan="1" colspan="1"><italic toggle="yes">Particle and Fibre Toxicology</italic></td><td align="center" rowspan="1" colspan="1">534</td></tr><tr><td align="left" rowspan="1" colspan="1">2013</td><td align="left" rowspan="1" colspan="1">Wang, YC<sup>[<xref rid="R13" ref-type="bibr">13</xref>]</sup></td><td align="left" rowspan="1" colspan="1">Comparison study of gold nanohexapods, nanorods, and nanocages for photothermal cancer treatment</td><td align="left" rowspan="1" colspan="1"><italic toggle="yes">ACS Nano</italic></td><td align="center" rowspan="1" colspan="1">530</td></tr><tr><td align="left" rowspan="1" colspan="1">2013</td><td align="left" rowspan="1" colspan="1">Yoon, HJ<sup>[<xref rid="R14" ref-type="bibr">14</xref>]</sup></td><td align="left" rowspan="1" colspan="1">Sensitive capture of circulating tumor cells by functionalized graphene oxide nanosheets</td><td align="left" rowspan="1" colspan="1"><italic toggle="yes">Nature Nanotechnology</italic></td><td align="center" rowspan="1" colspan="1">462</td></tr><tr><td align="left" rowspan="1" colspan="1">2015</td><td align="left" rowspan="1" colspan="1">Chen, Q<sup>[<xref rid="R15" ref-type="bibr">15</xref>]</sup></td><td align="left" rowspan="1" colspan="1">An imagable and photothermal &#8220;abraxane-like&#8221; nanodrug for combination cancer therapy to treat subcutaneous and metastatic breast tumors</td><td align="left" rowspan="1" colspan="1"><italic toggle="yes">Advanced Materials</italic></td><td align="center" rowspan="1" colspan="1">400</td></tr><tr><td align="left" rowspan="1" colspan="1">2021</td><td align="left" rowspan="1" colspan="1">Gaves, S<sup>[<xref rid="R16" ref-type="bibr">16</xref>]</sup></td><td align="left" rowspan="1" colspan="1">Nanoparticles for cancer therapy: current progress and challenges</td><td align="left" rowspan="1" colspan="1"><italic toggle="yes">Nanoscale Research Letters</italic></td><td align="center" rowspan="1" colspan="1">389</td></tr><tr><td align="left" rowspan="1" colspan="1">2017</td><td align="left" rowspan="1" colspan="1">Zang, AG<sup>[<xref rid="R17" ref-type="bibr">17</xref>]</sup></td><td align="left" rowspan="1" colspan="1">Tunable photoluminescence of water-soluble AgInZnS-graphene oxide (GO) nanocomposites and their application in-vivo bioimaging</td><td align="left" rowspan="1" colspan="1"><italic toggle="yes">Sensors and Actuators B: Chemical</italic></td><td align="center" rowspan="1" colspan="1">365</td></tr><tr><td align="left" rowspan="1" colspan="1">2017</td><td align="left" rowspan="1" colspan="1">Yao, XX<sup>[<xref rid="R18" ref-type="bibr">18</xref>]</sup></td><td align="left" rowspan="1" colspan="1">Graphene quantum dots-capped magnetic mesoporous silica nanoparticles as a multifunctional platform for controlled drug delivery, magnetic hyperthermia, and photothermal therapy</td><td align="left" rowspan="1" colspan="1"><italic toggle="yes">Small</italic></td><td align="center" rowspan="1" colspan="1">350</td></tr><tr><td align="left" rowspan="1" colspan="1">2012</td><td align="left" rowspan="1" colspan="1">Cheng, L<sup>[<xref rid="R19" ref-type="bibr">19</xref>]</sup></td><td align="left" rowspan="1" colspan="1">Multifunctional nanoparticles for upconversion luminescence/MR multimodal imaging and magnetically targeted photothermal therapy</td><td align="left" rowspan="1" colspan="1"><italic toggle="yes">Biomaterials</italic></td><td align="center" rowspan="1" colspan="1">321</td></tr></tbody></table></table-wrap>
</p></sec><sec><title>Analysis of keywords co-occurrence and hotspots</title><p>A total of 6359 keywords were identified in this dataset. Supplemental Digital Content Table S1 lists the 20 most frequent keywords. &#8220;Breast cancer,&#8221; &#8220;graphene oxide,&#8221; &#8220;nanoparticles,&#8221; &#8220;drug delivery,&#8221; and &#8220;graphene&#8221; were the five most frequent keywords (Fig. <xref rid="F6" ref-type="fig">6</xref>), indicating significant attention in this field.
<fig position="float" id="F6" orientation="portrait"><label>Figure 6.</label><caption><p>Keyword co-occurrence and hotspot analysis. (A&#8211;B) Keyword co-occurrence network. (C) Top 20 keywords with the strongest citation bursts. (D) Visualization and clustering network of keywords.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="js9-111-6305-g006.jpg"/></fig>
</p><p>The keyword co-occurrence network was established using all keywords, divided into six major clusters (Fig. <xref rid="F6" ref-type="fig">6</xref>a). Cluster 1 (red) primarily concerned the application of gold nanoparticles in BC. Cluster 2 (green) addressed graphene oxide-based drug delivery <italic toggle="yes">in vivo</italic> and photothermal therapy (PTT) applications. Cluster 3 (yellow) focused on &#8220;nanoparticles&#8221; and &#8220;graphene quantum dots.&#8221; Cluster 4 (dark blue) dealt mainly with topics related to reduced graphene oxide. Cluster 5 (purple) emphasized drug delivery applications of graphene materials, while Cluster 6 (light blue) concentrated on carbon nanotubes. &#8220;Graphene oxide,&#8221; &#8220;controlled-release,&#8221; &#8220;biosensor,&#8221; and &#8220;cytotoxicity&#8221; have become recent research hotspots (Fig. <xref rid="F6" ref-type="fig">6</xref>b).</p><p>The study further analyzed the top 18 keywords with the strongest citation bursts over 25&#160;years (Fig. <xref rid="F6" ref-type="fig">6</xref>c). The earliest burst keyword was &#8220;graphite oxide&#8221; (2010, strength&#160;=&#160;3.9). All keyword burst strengths were above 2.89, with five keywords above 5. &#8220;<italic toggle="yes">In vitro</italic>&#8221; showed the strongest citation burst (strength&#160;=&#160;7.88), emerging in 2014 and subsiding by 2017. Changes in keyword citation bursts reflect shifts in the research emphasis regarding graphene applications in BC. &#8220;Nano graphene&#8221; and &#8220;amplification&#8221; became hotspots from 2017, whereas &#8220;adsorption&#8221; and &#8220;antibacterial activity&#8221; emerged since 2020.</p><p>Figure <xref rid="F6" ref-type="fig">6</xref>d illustrates six clusters of varying colors and sizes, representing distinct research themes from the past 15&#160;years: #0 &#8220;biosensor,&#8221; #1 &#8220;photothermal therapy,&#8221; #2 &#8220;targeted delivery,&#8221; #3 &#8220;oxidative stress,&#8221; #4 &#8220;cancer cells,&#8221; and #5 &#8220;electrochemical sensor.&#8221; Clusters &#8220;#1 photothermal therapy&#8221; and &#8220;#5 electrochemical sensor&#8221; are relatively larger.</p><p>Keyword co-occurrence analysis revealed a research shift in graphene applications for BC, transitioning from traditional drug delivery to advanced diagnostics and therapies. Initially, research emphasized &#8220;drug delivery&#8221; and &#8220;nanoparticles,&#8221; highlighting graphene&#8217;s fundamental carrier properties. After 2010, interest surged in &#8220;photothermal therapy.&#8221; Following verification of its near-infrared (NIR) absorption capabilities, graphene was combined with &#8220;targeted delivery,&#8221; creating multifunctional therapeutic systems. Since 2013, &#8220;biosensors&#8221; and &#8220;electrochemical sensors&#8221; have gained prominence. Technological advances now enable precise detection of exosomes and circulating tumor miRNAs, enhancing early diagnosis. Recently emerging keywords, such as &#8220;multimodal therapy&#8221; and &#8220;nanographene amplification,&#8221; indicate a research evolution toward intelligent diagnostic and therapeutic platforms, aligning with innovative precision medicine demands.</p></sec><sec><title>Analysis of co-cited authors</title><p>Figure <xref rid="F7" ref-type="fig">7</xref> presents the author&#8217;s collaboration network diagram. A total of 279 authors participated in research related to graphene applications in BC. Among them, Duarte de Melo-Diogo was the most influential author, publishing 16 papers. Wei Qin had the highest total citations (730 times) and highest average citations per paper (66.36). Hassan Namazi achieved the highest H-index (12) (Table <xref rid="T6" ref-type="table">6</xref>).
<fig position="float" id="F7" orientation="portrait"><label>Figure 7.</label><caption><p>Analysis of co-cited authors. (A&#8211;B) Co-occurrence network of authors. (C) Top 4 authors with the strongest citation bursts.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="js9-111-6305-g007.jpg"/></fig>
<table-wrap position="float" id="T6" orientation="portrait"><label>Table 6</label><caption><p>Top 10 authors by publication count</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Authors</th><th align="left" rowspan="1" colspan="1">TP</th><th align="left" rowspan="1" colspan="1">TC</th><th align="left" rowspan="1" colspan="1">ACPP</th><th align="left" rowspan="1" colspan="1">H-index</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">de Melo-Diogo, Duarte</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">440</td><td align="center" rowspan="1" colspan="1">27.5</td><td align="center" rowspan="1" colspan="1">11</td></tr><tr><td align="left" rowspan="1" colspan="1">Namazi, Hassan</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">501</td><td align="center" rowspan="1" colspan="1">35.79</td><td align="center" rowspan="1" colspan="1">12</td></tr><tr><td align="left" rowspan="1" colspan="1">Correia, L. J.</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">436</td><td align="center" rowspan="1" colspan="1">31.14</td><td align="center" rowspan="1" colspan="1">11</td></tr><tr><td align="left" rowspan="1" colspan="1">Naghib, Seyed Morteza</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">488</td><td align="center" rowspan="1" colspan="1">34.86</td><td align="center" rowspan="1" colspan="1">9</td></tr><tr><td align="left" rowspan="1" colspan="1">Lima-Sousa, Rita</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">408</td><td align="center" rowspan="1" colspan="1">29.14</td><td align="center" rowspan="1" colspan="1">10</td></tr><tr><td align="left" rowspan="1" colspan="1">Rhee, Kyong Yop</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">6</td></tr><tr><td align="left" rowspan="1" colspan="1">Zare, Yasser</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">182</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">6</td></tr><tr><td align="left" rowspan="1" colspan="1">Alves, C&#225;tia</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">404</td><td align="center" rowspan="1" colspan="1">31.08</td><td align="center" rowspan="1" colspan="1">10</td></tr><tr><td align="left" rowspan="1" colspan="1">Hasanzadeh, Mohammad</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">571</td><td align="center" rowspan="1" colspan="1">47.58</td><td align="center" rowspan="1" colspan="1">11</td></tr><tr><td align="left" rowspan="1" colspan="1">Wei, Qin</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">730</td><td align="center" rowspan="1" colspan="1">66.36</td><td align="center" rowspan="1" colspan="1">11</td></tr></tbody></table></table-wrap>
</p><p>Figure <xref rid="F7" ref-type="fig">7</xref>c shows the citation activity of the top four authors. He Li had the longest citation burst duration (2013&#8211;2017), indicating his significant contribution to graphene applications in BC. Citation bursts for Yasser Zare, Kyong Yop Rhee, and Ana M. Diez-Pascual have been active since 2022, highlighting their innovative contributions to this field. Table <xref rid="T6" ref-type="table">6</xref> summarizes the TP, TC, ACPP, and H-index for the 10 authors with the highest total publications.</p><p>Duarte de Melo-Diogo emerged as a leading researcher in nano-mediated combination cancer therapy, utilizing a three-fold approach: material design, model innovation, and mechanism elucidation. His research concentrates on designing nanocarriers, developing tumor microenvironment-responsive delivery systems, and evaluating 3D models. His primary focus is on the synergistic combination of photothermal and photodynamic therapies (PTT/PDT) with chemotherapy and gene therapy. His contributions extend beyond creating highly effective, low-toxicity nanocarriers to establishing standardized 3D evaluation systems, advancing the field from material preparation toward clinical relevance. With ongoing research in injectable hydrogels and immune-combination strategies, his work significantly influences the translational trajectory of cancer therapy.</p><p>Wei Qin developed distinct expertise in biomedical nanomaterials through three core technologies: environmentally responsive material design, multimodal signal amplification, and tumor microenvironment analysis. His research addresses key challenges in targeting, sensitivity, and safety of nanocarriers. Furthermore, his work accelerates the transition of nanomaterials from laboratory research to practical application through validation in 3D tumor models and preclinical translational studies. Qin&#8217;s integrative &#8220;materials &#8211; devices &#8211; therapeutic efficacy&#8221; approach offers nanomaterial-based solutions for critical medical issues, including cancer treatment and early diagnosis.</p><p>Since 2022, authors such as Yasser Zare and Kyong Yop Rhee have notably contributed to research focusing on &#8220;electrochemical sensors-exosome detection.&#8221; Keywords such as &#8220;amplification&#8221; and &#8220;circulating tumor miRNAs&#8221; appear frequently in highly cited recent literature. Meanwhile, Ana M. Diez-Pascual focuses her research on elucidating the antitumor mechanisms of graphene-based composites.</p></sec><sec><title>Analysis of co-cited references</title><p>Over the past 15&#160;years, a total of 248 studies on graphene applications in BC have been co-cited. The most frequently cited reference, &#8220;Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries,&#8221; was published by Sung <italic toggle="yes">et al</italic> in CA: A Cancer Journal for Clinicians in 2021. The reference with the highest centrality (0.53) was &#8220;Development of a Graphene Oxide Nanocarrier for Dual-Drug Chemo-phototherapy to Overcome Drug Resistance in Cancer,&#8221; published in ACS Applied Materials &amp; Interfaces in 2015. Table <xref rid="T7" ref-type="table">7</xref> provides detailed information on the top 10 cited references. Each reference was cited at least 16 times.
<table-wrap position="float" id="T7" orientation="portrait"><label>Table 7</label><caption><p>Top 10 co-cited references</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Title</th><th align="left" rowspan="1" colspan="1">First author</th><th align="left" rowspan="1" colspan="1">Year</th><th align="left" rowspan="1" colspan="1">Journal</th><th align="left" rowspan="1" colspan="1">TC</th><th align="left" rowspan="1" colspan="1">Co-citation</th><th align="left" rowspan="1" colspan="1">Centrality</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries<sup>[<xref rid="R1" ref-type="bibr">1</xref>]</sup></td><td align="left" rowspan="1" colspan="1">Sung H</td><td align="center" rowspan="1" colspan="1">2021</td><td align="left" rowspan="1" colspan="1"><italic toggle="yes">CA-A Cancer Journal for Clinicians</italic></td><td align="center" rowspan="1" colspan="1">46&#160;748</td><td align="center" rowspan="1" colspan="1">29</td><td align="center" rowspan="1" colspan="1">0.08</td></tr><tr><td align="left" rowspan="1" colspan="1">Nano-graphene in biomedicine: theranostic applications<sup>[<xref rid="R20" ref-type="bibr">20</xref>]</sup></td><td align="left" rowspan="1" colspan="1">Yang K</td><td align="center" rowspan="1" colspan="1">2013</td><td align="left" rowspan="1" colspan="1"><italic toggle="yes">Chemical Society Reviews</italic></td><td align="center" rowspan="1" colspan="1">1372</td><td align="center" rowspan="1" colspan="1">26</td><td align="center" rowspan="1" colspan="1">0.15</td></tr><tr><td align="left" rowspan="1" colspan="1">An electrochemical nanobiosensor for plasma miRNA-155, based on graphene oxide and gold nanorod, for early detection of BC<sup>[<xref rid="R21" ref-type="bibr">21</xref>]</sup></td><td align="left" rowspan="1" colspan="1">Azimzadeh M</td><td align="center" rowspan="1" colspan="1">2016</td><td align="left" rowspan="1" colspan="1"><italic toggle="yes">Biosens Bioelectron</italic></td><td align="center" rowspan="1" colspan="1">274</td><td align="center" rowspan="1" colspan="1">26</td><td align="center" rowspan="1" colspan="1">0.18</td></tr><tr><td align="left" rowspan="1" colspan="1">Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy<sup>[<xref rid="R22" ref-type="bibr">22</xref>]</sup></td><td align="left" rowspan="1" colspan="1">Yang K</td><td align="center" rowspan="1" colspan="1">2010</td><td align="left" rowspan="1" colspan="1"><italic toggle="yes">Nano Letters</italic></td><td align="center" rowspan="1" colspan="1">2096</td><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs<sup>[<xref rid="R10" ref-type="bibr">10</xref>]</sup></td><td align="left" rowspan="1" colspan="1">Zhang LM</td><td align="center" rowspan="1" colspan="1">2010</td><td align="left" rowspan="1" colspan="1"><italic toggle="yes">Small</italic></td><td align="center" rowspan="1" colspan="1">1501</td><td align="center" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">0.04</td></tr><tr><td align="left" rowspan="1" colspan="1">Ultrasmall reduced graphene oxide with high near-infrared absorbance for photothermal therapy<sup>[<xref rid="R23" ref-type="bibr">23</xref>]</sup></td><td align="left" rowspan="1" colspan="1">Robinson JT</td><td align="center" rowspan="1" colspan="1">2011</td><td align="left" rowspan="1" colspan="1"><italic toggle="yes">Journal of The American Chemical Society</italic></td><td align="center" rowspan="1" colspan="1">1848</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">0.13</td></tr><tr><td align="left" rowspan="1" colspan="1">In vivo targeting of metastatic BC via tumor vasculature-specific nano-graphene oxide<sup>[<xref rid="R24" ref-type="bibr">24</xref>]</sup></td><td align="left" rowspan="1" colspan="1">Yang DZ</td><td align="center" rowspan="1" colspan="1">2016</td><td align="left" rowspan="1" colspan="1"><italic toggle="yes">Biomaterials</italic></td><td align="center" rowspan="1" colspan="1">99</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">0.16</td></tr><tr><td align="left" rowspan="1" colspan="1">The chemistry of graphene oxide<sup>[<xref rid="R25" ref-type="bibr">25</xref>]</sup></td><td align="left" rowspan="1" colspan="1">Dreyer DR</td><td align="center" rowspan="1" colspan="1">2010</td><td align="left" rowspan="1" colspan="1"><italic toggle="yes">Chemical Society Reviews</italic></td><td align="center" rowspan="1" colspan="1">9547</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">0.2</td></tr><tr><td align="left" rowspan="1" colspan="1">Graphene and graphene oxide as new nanocarriers for drug delivery applications<sup>[<xref rid="R26" ref-type="bibr">26</xref>]</sup></td><td align="left" rowspan="1" colspan="1">Liu JQ</td><td align="center" rowspan="1" colspan="1">2013</td><td align="left" rowspan="1" colspan="1"><italic toggle="yes">Acta Biomaterialia</italic></td><td align="center" rowspan="1" colspan="1">1048</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">0.07</td></tr><tr><td align="left" rowspan="1" colspan="1"><italic toggle="yes">In vitro</italic> toxicity evaluation of graphene oxide on A549 cells<sup>[<xref rid="R27" ref-type="bibr">27</xref>]</sup></td><td align="left" rowspan="1" colspan="1">Chang YL</td><td align="center" rowspan="1" colspan="1">2011</td><td align="left" rowspan="1" colspan="1"><italic toggle="yes">Toxicology Letters</italic></td><td align="center" rowspan="1" colspan="1">1097</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">0.28</td></tr></tbody></table></table-wrap>
</p><p>Figure <xref rid="F8" ref-type="fig">8</xref>b illustrates the top 15 references with the strongest citation bursts, which began appearing as early as 2008. All these references had burst intensities greater than 3, with 11 references exceeding a strength of 5, and 2 references surpassing a strength of 10. The strongest citation burst (Strength&#160;=&#160;12.54) occurred for a reference published in 2015.
<fig position="float" id="F8" orientation="portrait"><label>Figure 8.</label><caption><p>Analysis of co-cited references. (A) Co-citation network map. (B) Top 20 references with the strongest citation bursts.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="js9-111-6305-g008.jpg"/></fig>
</p><p>Graphene research in BC exhibits a &#8220;bench-to-bedside&#8221; trajectory. Zhang <italic toggle="yes">et al</italic><sup>[<xref rid="R10" ref-type="bibr">10</xref>]</sup> pioneered the development of a graphene oxide-based targeted drug delivery system, establishing an active targeting paradigm. Robinson <italic toggle="yes">et al</italic><sup>[<xref rid="R23" ref-type="bibr">23</xref>]</sup> addressed efficiency and toxicity issues in PTT by creating ultra-small reduced graphene oxide. Yang <italic toggle="yes">et al</italic><sup>[<xref rid="R20" ref-type="bibr">20</xref>]</sup> systematically summarized interdisciplinary applications in their comprehensive &#8220;theranostics&#8221; review, while Dreyer <italic toggle="yes">et al</italic><sup>[<xref rid="R25" ref-type="bibr">25</xref>]</sup> provided essential chemical insights into graphene oxide, supporting toxicity evaluations and material modifications. These seminal publications form the core of co-citation networks, directly influencing research hotspots such as &#8220;photothermal therapy&#8221; and &#8220;biosensing,&#8221; thus laying theoretical and technical foundations for clinical translation.</p></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>To our knowledge, this is the first comprehensive bibliometric analysis of graphene application research in BC. Findings indicate a generally upward trend in publication numbers. An increasing number of countries, institutions, and researchers have become involved in this area, accelerating its rapid advancement.</p><p>BC remains a leading cause of death among women globally. Although substantial progress has been made in BC diagnosis and treatment, managing drug resistance, advanced disease stages, and adverse treatment events remains challenging. There is an ongoing need to develop targeted and specific drug-delivery systems to enhance therapeutic efficiency and minimize toxicity from nonspecific drug distribution<sup>[<xref rid="R28" ref-type="bibr">28</xref>]</sup>. Graphene exhibits inherent anticancer properties, enhancing cell adhesion and capturing BC cells<sup>[<xref rid="R29" ref-type="bibr">29</xref>]</sup>. Studies indicate graphene&#8217;s potential cytotoxic effects on tumor cells through oxidative stress and autophagy<sup>[<xref rid="R30" ref-type="bibr">30</xref>]</sup>. Additionally, graphene reduces macrophage activity, induces oxidative damage, inhibits BC cell migration and invasion, and suppresses tumor growth and metastasis<sup>[<xref rid="R31" ref-type="bibr">31</xref>]</sup>. Previous research demonstrates that graphene exhibits relatively low toxicity to normal cells at conventional concentrations. Modified graphene displays enhanced active targeting, accumulates effectively at tumor sites, and is gradually cleared from the body, highlighting excellent biocompatibility and biosafety<sup>[<xref rid="R32" ref-type="bibr">32</xref>]</sup>.</p><sec><title>The application of graphene in PTT for BC</title><p>Currently, conventional BC treatments still have limitations, including adverse side effects, multidrug resistance, and cancer recurrence<sup>[<xref rid="R33" ref-type="bibr">33</xref>]</sup>. To overcome these drawbacks, PTT based on light irradiation has been introduced to control BC effectively. This method is noninvasive, low-toxicity, highly efficient, and controllable<sup>[<xref rid="R34" ref-type="bibr">34</xref>]</sup>. The mechanism of PTT involves destroying cancer cells by generating heat or reactive oxygen species (ROS) after irradiating lesions, particularly with NIR light<sup>[<xref rid="R35" ref-type="bibr">35</xref>]</sup>. PTT induces cellular stress, activates autophagy-related genes, and initiates autophagy to influence the survival, differentiation, or death of cancer cells<sup>[<xref rid="R36" ref-type="bibr">36</xref>]</sup>.</p><p>However, PTT in BC faces challenges, including the limited penetration depth of NIR irradiation and low photothermal conversion efficiency, resulting in incomplete tumor ablation and higher recurrence risk<sup>[<xref rid="R37" ref-type="bibr">37</xref>]</sup>. To address these limitations, photosensitizers must exhibit high NIR-region absorption and selective uptake by BC cells, enabling precise heating of tumor cells<sup>[<xref rid="R38" ref-type="bibr">38</xref>]</sup>. Graphene&#8217;s excellent NIR absorption and surface activity give it considerable potential as a photothermal therapeutic agent for BC<sup>[<xref rid="R39" ref-type="bibr">39</xref>]</sup>. Incorporating targeting agents into graphene enhances its specificity, improving the ablation effect of PTT<sup>[<xref rid="R40" ref-type="bibr">40</xref>]</sup>. Additionally, graphene-based multifunctional hybrid nanomaterials exhibit stronger photothermal effects<sup>[<xref rid="R41" ref-type="bibr">41</xref>]</sup>. Typically, high-power NIR irradiation is used to achieve deeper penetration but risks damaging surrounding normal tissues, especially during prolonged irradiation. Nevertheless, graphene-based nanocomposites effectively kill BC cells even under low-intensity lasers<sup>[<xref rid="R42" ref-type="bibr">42</xref>]</sup>.</p><p>The HPAA/GO-RGD@DOX system designed by Zhu <italic toggle="yes">et al</italic><sup>[<xref rid="R43" ref-type="bibr">43</xref>]</sup> utilizes GO as a carrier, surface-modified with poly(&#946;-amino ester) and grafted with RGD peptides for doxorubicin (DOX) loading. Employing pH-responsive chemical bonds, this system releases drugs in the acidic tumor microenvironment and achieves combined photothermal-chemotherapy via NIR laser irradiation<sup>[<xref rid="R43" ref-type="bibr">43</xref>]</sup>. Zhou <italic toggle="yes">et al</italic><sup>[<xref rid="R44" ref-type="bibr">44</xref>]</sup> utilized 3D printing technology to produce polyurethane scaffolds functionalized with graphene nanosheets. Leveraging 4D printing properties, these scaffolds act as stimulus-responsive tissue expanders <italic toggle="yes">in vivo</italic> and as photothermal ablation agents under laser irradiation.</p><p>Chen <italic toggle="yes">et al</italic><sup>[<xref rid="R45" ref-type="bibr">45</xref>]</sup> developed a hierarchical drug delivery system using rGO nanosheets as photosensitizers. Through surface modification, the system co-delivers anti-PD-L1 antibodies and exosome inhibitors. Combined with PTT, it activates systemic antitumor immunity and remodels the tumor immune microenvironment<sup>[<xref rid="R45" ref-type="bibr">45</xref>]</sup>. Itoo <italic toggle="yes">et al</italic><sup>[<xref rid="R46" ref-type="bibr">46</xref>]</sup> synthesized GO(OX)PB(1/1/0.2)NPs nanocomposites by conjugating polyethylene glycol (PEG)-modified graphene oxide with oxaliplatin prodrugs and PEGylated biotin. Precise ratio optimization ensures targeted delivery via biotin binding, enabling synergistic chemotherapy and photothermal therapy<sup>[<xref rid="R46" ref-type="bibr">46</xref>]</sup>.</p><p>All four research teams introduced innovative BC treatment methods through novel material designs and combined strategies. These methodologies integrate material preparation, performance optimization, and therapeutic design. Both <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in vivo</italic> experiments demonstrated significant tumor suppression, providing new effective pathways and potential solutions for BC therapy.</p></sec><sec><title>The application of graphene as a biosensor in BC</title><p>BC remains one of the leading causes of cancer-related death among women<sup>[<xref rid="R47" ref-type="bibr">47</xref>]</sup>. Early BC detection facilitates timely treatment, reduces mortality, and improves patient survival rates. Current detection methods include imaging, genetic screening, and tumor marker detection<sup>[<xref rid="R48" ref-type="bibr">48</xref>]</sup>. However, imaging techniques lack sufficient sensitivity and specificity for accurate detection of small early-stage lesions and do not enable real-time tumor imaging, failing to meet clinical requirements for early diagnosis<sup>[<xref rid="R49" ref-type="bibr">49</xref>]</sup>. Additionally, these methods are time-consuming, expensive, and can yield false-positive or false-negative results<sup>[<xref rid="R50" ref-type="bibr">50</xref>]</sup>. They may also lead to complications or even cause cancer or other diseases<sup>[<xref rid="R51" ref-type="bibr">51</xref>]</sup>. With the ongoing advancement of nanotechnology, graphene-based biosensors have attracted considerable attention. They offer advantages such as high sensitivity and specificity, rapid analysis, label-free detection, low cost, excellent biocompatibility, miniaturization, and integration of diagnostic and therapeutic functions, presenting promising opportunities for early BC detection<sup>[<xref rid="R52" ref-type="bibr">52</xref>]</sup>. Recently, biosensors have garnered attention for early BC diagnosis due to their superior sensitivity, simplicity, low cost, and low detection limits compared to conventional methods<sup>[<xref rid="R53" ref-type="bibr">53</xref>]</sup>.</p><p>Khodaie <italic toggle="yes">et al</italic><sup>[<xref rid="R54" ref-type="bibr">54</xref>]</sup> constructed a surface plasmon resonance sensor integrating graphene with MXene to detect carcinoembryonic antigen. Sun <italic toggle="yes">et al</italic><sup>[<xref rid="R55" ref-type="bibr">55</xref>]</sup> developed a flexible biosensor based on field-effect transistors, demonstrating potential for wearable devices capable of detecting miRNA in sweat. Yu <italic toggle="yes">et al</italic><sup>[<xref rid="R56" ref-type="bibr">56</xref>]</sup> designed an endonuclease-triggered detection platform combining oligonucleotide probes with graphene oxide to quantitatively measure miR-1246, exhibiting significantly enhanced sensitivity over enzyme-free systems and effectively distinguishing patients from healthy controls in clinical trials. Garc&#237;a-Fern&#225;ndez <italic toggle="yes">et al</italic><sup>[<xref rid="R57" ref-type="bibr">57</xref>]</sup> developed an electrochemiluminescent DNA biosensor incorporating graphene nanosheets, capable of identifying single mutations in the BRCA1 gene with extremely low detection limits, validated through real sample analysis. Guo <italic toggle="yes">et al</italic><sup>[<xref rid="R58" ref-type="bibr">58</xref>]</sup> created an electrochemiluminescent cell sensor using PtCo@rGO nanozymes and Au@CNTs bioconjugates, enabling broad linear-range detection of circulating tumor cells in BC, with single-cell-level sensitivity. Parihar <italic toggle="yes">et al</italic><sup>[<xref rid="R59" ref-type="bibr">59</xref>]</sup> fabricated a cerium oxide-graphene oxide nanocomposite aptasensor for noninvasive EGFR detection via electrochemical impedance spectroscopy, suitable for real-time clinical monitoring.</p><p>All six studies employed graphene or its derivatives as core materials, functionalized by composite formation or biomolecular conjugation. Utilizing diverse optical and electrical detection methods, these systems achieved ultrasensitive detection of BC-related biomarkers. Results consistently demonstrated extremely low detection limits, surpassing traditional methods. Both <italic toggle="yes">ex vivo</italic> experiments and clinical validations effectively distinguished BC patients from healthy individuals, highlighting advantages such as noninvasive or minimally invasive detection. Collectively, these studies provide innovative technological solutions and direction for early diagnosis, real-time monitoring, and personalized medicine in BC management.</p></sec><sec><title>Contribution to existing literature</title><p>This study contributes significantly to the existing literature by providing the first systematic and quantitative bibliometric analysis specifically examining graphene applications in breast cancer. Unlike prior qualitative reviews, our approach identifies key institutions, authors, journals, and trends through objective bibliometric tools. This enhances understanding of global research dynamics and highlights shifts in research hotspots toward precision medicine, photothermal therapy, and advanced biosensing.</p></sec><sec><title>Future applications of graphene in BC</title><sec><title>How can graphene-based nanomedicine contribute to precision medicine in BC treatment?</title><p>In precision therapy for BC, the multifunctional properties of graphene significantly contribute through interdisciplinary innovation. Its two-dimensional planar structure and modifiable surface allow efficient targeted drug delivery. Functionalized GO loaded with dual drugs enables pH-responsive release in the acidic tumor microenvironment<sup>[<xref rid="R10" ref-type="bibr">10</xref>]</sup>. Graphene&#8217;s photothermal conversion property, combined with chemotherapy, produces a synergistic effect, facilitating simultaneous thermal ablation and drug release under NIR irradiation<sup>[<xref rid="R60" ref-type="bibr">60</xref>]</sup>. A hybrid graphene oxide-GQD system improves chemotherapeutic drug delivery efficiency through photothermal disruption of cancer cell membranes<sup>[<xref rid="R61" ref-type="bibr">61</xref>]</sup>. The fluorescence imaging capability of GQDs promotes theranostic platform development, while GO-functionalized surface-enhanced Raman scattering (SERS) immunosensors enable picogram-level detection of BC biomarkers<sup>[<xref rid="R62" ref-type="bibr">62</xref>]</sup>. Magnetic GO nanoparticles combined with MRI-guided PTT permit real-time monitoring of nanoparticle distribution and temperature<sup>[<xref rid="R63" ref-type="bibr">63</xref>]</sup>. Surface modifications such as chitosan coating and phosphoramidate functionalization substantially enhance graphene&#8217;s biocompatibility, reducing hematotoxicity and ROS generation<sup>[<xref rid="R64" ref-type="bibr">64</xref>]</sup>. Both <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in vivo</italic> studies confirmed its biosafety<sup>[<xref rid="R65" ref-type="bibr">65</xref>]</sup>. These integrated properties &#8211; encompassing material science-based carrier design, oncology-based target analysis, and biomedical engineering-driven technological translation &#8211; provide comprehensive solutions for precision medicine in BC, including targeted delivery, synergistic therapy, real-time monitoring, and safety optimization.</p></sec><sec><title>Challenges in clinical translation of graphene</title><p>Graphene shows promising potential in BC therapy due to its unique physicochemical properties. However, clinical translation faces several obstacles, including toxicity risks, complex regulatory processes, and challenges in large-scale production. Addressing these requires interdisciplinary research and technological innovation. Graphene&#8217;s nanoscale dimensions and surface properties may induce biotoxicity, such as oxidative stress and cellular damage. Nevertheless, surface functionalization significantly enhances biocompatibility. Increasing research focuses on reducing hemotoxicity using polymer coatings<sup>[<xref rid="R66" ref-type="bibr">66</xref>]</sup>. Experimental and theoretical studies of phosphoramide-functionalized GO demonstrate that specific functional group modifications can modulate material-biointerface interactions, decreasing nonspecific adsorption and toxicity<sup>[<xref rid="R64" ref-type="bibr">64</xref>]</sup>.</p><p>The interdisciplinary nature of graphene-based nanomedicine complicates regulatory pathways. Regulatory agencies, such as the U.S. Food and Drug Administration, currently require comprehensive data on material characterization, pharmacokinetics, and toxicology for nanomedicine approval. However, standardized detection methods for critical parameters, including graphene size distribution and charge state, remain lacking. For instance, batch-to-batch variations in GO-functionalized SERS immunoassay platforms, used for parallel analysis of BC cells and proteins, may impact diagnostic accuracy<sup>[<xref rid="R62" ref-type="bibr">62</xref>]</sup>. Additionally, the complex mechanisms underlying multifunctional graphene nanosystems integrating imaging and therapeutic capabilities are incompatible with traditional evaluation models designed for single-target drugs<sup>[<xref rid="R65" ref-type="bibr">65</xref>]</sup>.</p><p>Industrial-scale graphene production is limited by low yield, insufficient purity, and complex manufacturing processes. While chemical vapor deposition can produce high-quality graphene, the high equipment cost and energy consumption hinder its pharmaceutical-grade application. Although redox methods are more economical, they often introduce oxygen-containing groups and metal impurities, compromising material uniformity<sup>[<xref rid="R10" ref-type="bibr">10</xref>]</sup>. Emerging techniques like ultrasound-assisted liquid-phase exfoliation improve graphene dispersibility and yield, but solvent recovery and environmental concerns in large-scale production remain unresolved.</p><p>Despite these challenges, graphene-based nanomaterials hold considerable promise for BC therapy. Establishing standardized frameworks for systematic toxicity assessment and dose-effect relationship characterization, fostering collaboration between academia and regulatory agencies to develop standardized guidelines for structural characterization, quality control, and efficacy evaluation, and advancing cost-effective, scalable, and environmentally friendly synthesis methods could accelerate graphene&#8217;s translation from laboratory research into clinical practice.</p></sec><sec sec-type="materials"><title>Interdisciplinary collaboration among materials science, oncology, and biomedical engineering</title><p>In BC diagnosis and treatment, interdisciplinary collaboration among materials science, oncology, and biomedical engineering has established an innovative research paradigm. Materials science addresses precise drug delivery by designing functionalized graphene-based targeted carriers<sup>[<xref rid="R66" ref-type="bibr">66</xref>]</sup>. These carriers undergo surface modification with targeting peptides or responsive groups, directly anchoring to specific targets identified by oncology research<sup>[<xref rid="R62" ref-type="bibr">62</xref>]</sup>. Oncology provides pathological mechanisms guiding material design. For example, based on EMT pathway dysregulation, PEG-GO@XN nanocomposites were developed to inhibit BC metastasis, with efficacy and safety validated through 3D tumor spheroid models and animal orthotopic transplantation experiments<sup>[<xref rid="R67" ref-type="bibr">67</xref>]</sup>. Biomedical engineering acts as a translational bridge, integrating graphene&#8217;s photothermal and fluorescence imaging capabilities into a theranostic platform. This platform enables real-time MRI monitoring of drug distribution and therapeutic response, while establishing standardized multiscale evaluation systems<sup>[<xref rid="R63" ref-type="bibr">63</xref>]</sup>. This collaborative framework of &#8220;material design&#8211;mechanism validation&#8211;technology implementation&#8221; not only addresses therapeutic bottlenecks arising from BC heterogeneity but also advances graphene-based nanomedicine toward personalized precision medicine.</p></sec></sec></sec><sec sec-type="conclusions"><title>Conclusion</title><p>Current BC diagnosis and treatment face multiple challenges, including insufficiently specific biomarkers, large sample size requirements, and lengthy clinical testing. Although graphene-based biosensors offer advantages such as high sensitivity and wide dynamic detection ranges, bottlenecks in large-scale production, stability, and biocompatibility must be overcome.</p><p>Future research should focus on three directions: (1) developing graphene-based multimarker detection platforms integrating HER2-ECD, circulating tumor miRNA, and exosome detection, coupled with AI algorithms to create intelligent diagnostic models and address insufficient precision from single biomarkers; (2) optimizing biocompatibility via atomic-layer deposition and biomimetic modifications to achieve tumor microenvironment-specific drug release linked with photothermal effects, balancing anticancer efficacy and toxicity; (3) establishing collaborative networks of &#8220;material scientists-clinical pathologists-AI engineers&#8221; to validate graphene sensors&#8217; clinical applicability using 3D-bioprinted tumor models, while advancing green synthesis technologies and standardized production methods to accelerate clinical translation. Additionally, graphene&#8217;s potential in gene-editing vectors, multidrug-resistance reversal, and combined immunotherapy warrants further interdisciplinary exploration. Only through breakthroughs in collaborative innovation in &#8220;detection accuracy-material toxicity-production standardization&#8221; can graphene transition from &#8220;proof of concept&#8221; to clinical implementation, reshaping precision BC diagnosis and treatment.</p><p>Graphene applications in BC have advanced from &#8220;material exploration&#8221; to the critical stage of &#8220;precision diagnosis and treatment.&#8221; The global knowledge graph constructed in this study systematically summarizes the past 15&#160;years of research and serves as a &#8220;navigation map&#8221; for future developments. By quantitatively analyzing technical bottlenecks and cutting-edge directions, it provides an actionable roadmap for graphene&#8217;s translation from laboratory research to clinical practice, driving BC management toward &#8220;efficiency, minimally invasive procedures, and personalization.&#8221;</p><p>In summary, our bibliometric analysis clearly identifies the field&#8217;s unique contributions and future challenges, offering valuable insights and practical guidance for researchers pursuing clinical translation of graphene-based technologies in BC.</p></sec><sec><title>Strengths and limitations</title><p>This study has several unique strengths. First, it systematically analyzed graphene research in BC using bibliometric methods for the first time, providing comprehensive guidance for researchers. Second, two widely used bibliometric tools were employed simultaneously, likely ensuring objectivity in data analysis. Lastly, compared with traditional reviews, bibliometric analysis offers a more comprehensive understanding of research hotspots and frontiers.</p><p>However, this study also has limitations. First, the analysis was based solely on the WoSCC database, potentially omitting relevant studies from other sources. Second, studies were limited to English-language publications, underrepresenting non-English literature. Lastly, the 2024 dataset was incomplete, covering only publications until November 20.
</p></sec></body><back><ack><title>Acknowledgements</title><p>Not applicable.</p></ack><fn-group><fn fn-type="other"><p>Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.</p></fn><fn fn-type="other"><p>Supplemental Digital Content is available for this article. Direct URL citations are provided in the HTML and PDF versions of this article on the journal's website, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="www.lww.com/international-journal-of-surgery" ext-link-type="uri">www.lww.com/international-journal-of-surgery</ext-link>.</p></fn><fn fn-type="equal"><p>Published online 25 June 2025</p></fn></fn-group><sec><title>Ethical approval</title><p>Given that the data originated from the publicly accessible WoSCC database, obtaining ethical approval from an institutional review board was deemed unnecessary.</p></sec><sec><title>Consent</title><p>Ethical approval and patient consent were not required for the analyses conducted, as they were solely based on literature research.</p></sec><sec><title>Sources of funding</title><p>This work was supported by the National Natural Science Foundation of China (No.82374452) to Jingwei Li.</p></sec><sec><title>Author contributions</title><p>Conceptualization: M.Z. and J.L.; data collection, analysis and data standardization: M.Z., D.P., and M.Y.; original draft preparation: M.Z.; review and editing: G.S. and J.L.; visualization: M.Z. and D.P. All authors contributed to the article and approved the submitted version.</p></sec><sec sec-type="COI-statement"><title>Conflicts of interest disclosure</title><p>The authors declare no potential conflicts of interest with respect to this research, including any commercial or financial relationships.</p></sec><sec><title>Research registration unique identifying number (UIN)</title><p>It is not necessary for this research to have Research Registration Unique Identifying Number (UIN).</p></sec><sec><title>Guarantor</title><p>Jingwei Li.</p></sec><sec><title>Provenance and peer review</title><p>Not commissioned, externally peer-reviewed.</p></sec><sec sec-type="data-availability"><title>Data availability statement</title><p>The data sets generated and analyzed during the study are publicly available. Access to the data can be provided through the Web of Science Core Collection. All data used in this study are included within the manuscript or available as Supplemental Digital Content.</p></sec><ref-list><title>References</title><ref id="R1"><label>[1]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sung</surname><given-names>H</given-names></name><name name-style="western"><surname>Ferlay</surname><given-names>J</given-names></name><name name-style="western"><surname>Siegel</surname><given-names>RL</given-names></name><etal/></person-group>. <article-title>Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries</article-title>. <source>CA Cancer J Clin</source><year>2021</year>;<volume>71</volume>:<fpage>209&#8211;49</fpage>.<pub-id pub-id-type="pmid">33538338</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3322/caac.21660</pub-id></mixed-citation></ref><ref id="R2"><label>[2]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Santerre</surname><given-names>JP</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Du</surname><given-names>Z</given-names></name><etal/></person-group>. <article-title>Biomaterials&#8217; enhancement of immunotherapy for breast cancer by targeting functional cells in the tumor micro-environment</article-title>. <source>Front Immunol</source><year>2024</year>;<volume>15</volume>:<fpage>1492323</fpage>.<pub-id pub-id-type="pmid">39600709</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2024.1492323</pub-id><pub-id pub-id-type="pmcid">PMC11588700</pub-id></mixed-citation></ref><ref id="R3"><label>[3]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rahimi</surname><given-names>S</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zareian</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Cellular and subcellular interactions of graphene-based materials with cancerous and non-cancerous cells</article-title>. <source>Adv Drug Deliv Rev</source><year>2022</year>;<volume>189</volume>:<fpage>114467</fpage>.<pub-id pub-id-type="pmid">35914588</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.addr.2022.114467</pub-id></mixed-citation></ref><ref id="R4"><label>[4]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ria</surname><given-names>T</given-names></name><name name-style="western"><surname>Roy</surname><given-names>R</given-names></name><name name-style="western"><surname>Mandal</surname><given-names>US</given-names></name><etal/></person-group>. <article-title>Prospects of nano-theranostic approaches against breast and cervical cancer</article-title>. <source>Biochim Biophys Acta Rev Cancer</source><year>2024</year>;<volume>1879</volume>:<fpage>189227</fpage>.<pub-id pub-id-type="pmid">39612962</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bbcan.2024.189227</pub-id></mixed-citation></ref><ref id="R5"><label>[5]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></name><name name-style="western"><surname>Gong</surname><given-names>J</given-names></name><name name-style="western"><surname>Deng</surname><given-names>X</given-names></name><etal/></person-group>. <article-title>Curcumin and nanodelivery systems: new directions for targeted therapy and diagnosis of breast cancer</article-title>. <source>Biomed Pharmacother</source><year>2024</year>;<volume>180</volume>:<fpage>117404</fpage>.<pub-id pub-id-type="pmid">39307117</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.biopha.2024.117404</pub-id></mixed-citation></ref><ref id="R6"><label>[6]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Agha</surname><given-names>RA</given-names></name><name name-style="western"><surname>Mathew</surname><given-names>G</given-names></name><name name-style="western"><surname>Rashid</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Transparency In The Reporting of Artificial INtelligence &#8211; the TITAN guideline</article-title>. <source>Premier J Sci</source><year>2025</year>;<volume>10</volume>:<fpage>100082</fpage>.</mixed-citation></ref><ref id="R7"><label>[7]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xia</surname><given-names>DM</given-names></name><name name-style="western"><surname>Wang</surname><given-names>XR</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>PY</given-names></name><etal/></person-group>. <article-title>Research progress of heat stroke during 1989-2019: a bibliometric analysis</article-title>. <source>Mil Med Res</source><year>2021</year>; <volume>8</volume>:<fpage>5</fpage>.<pub-id pub-id-type="pmid">33472705</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s40779-021-00300-z</pub-id><pub-id pub-id-type="pmcid">PMC7818934</pub-id></mixed-citation></ref><ref id="R8"><label>[8]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Eck</surname><given-names>NJ</given-names></name><name name-style="western"><surname>Waltman</surname><given-names>L</given-names></name></person-group>. <article-title>Software survey: vOSviewer, a computer program for bibliometric mapping</article-title>. <source>Scientometrics</source>. <year>2010</year>;<volume>84</volume>:<fpage>523&#8211;38</fpage><pub-id pub-id-type="pmid">20585380</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11192-009-0146-3</pub-id><pub-id pub-id-type="pmcid">PMC2883932</pub-id></mixed-citation></ref><ref id="R9"><label>[9]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>C</given-names></name></person-group>. <article-title>Searching for intellectual turning points: progressive knowledge domain visualization</article-title>. <source>Proc Natl Acad Sci U S A</source><year>2004</year>;<volume>101</volume>:<fpage>5303&#8211;10</fpage>.<pub-id pub-id-type="pmid">14724295</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.0307513100</pub-id><pub-id pub-id-type="pmcid">PMC387312</pub-id></mixed-citation></ref><ref id="R10"><label>[10]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name><name name-style="western"><surname>Xia</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Q</given-names></name><etal/></person-group>. <article-title>Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs</article-title>. <source>Small</source><year>2010</year>;<volume>6</volume>:<fpage>537&#8211;44</fpage>.<pub-id pub-id-type="pmid">20033930</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/smll.200901680</pub-id></mixed-citation></ref><ref id="R11"><label>[11]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tao</surname><given-names>W</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>X</given-names></name><name name-style="western"><surname>Yu</surname><given-names>X</given-names></name><etal/></person-group>. <article-title>Black phosphorus nanosheets as a robust delivery platform for cancer theranostics</article-title>. <source>Adv Mater</source><year>2017</year>;<volume>29</volume>:<fpage>10</fpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/adma.201603276</pub-id><pub-id pub-id-type="pmcid">PMC5205548</pub-id><pub-id pub-id-type="pmid">27797119</pub-id></mixed-citation></ref><ref id="R12"><label>[12]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ou</surname><given-names>L</given-names></name><name name-style="western"><surname>Song</surname><given-names>B</given-names></name><name name-style="western"><surname>Liang</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Toxicity of graphene-family nanoparticles: a general review of the origins and mechanisms</article-title>. <source>Part Fibre Toxicol</source><year>2016</year>;<volume>13</volume>:<fpage>57</fpage>.<pub-id pub-id-type="pmid">27799056</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12989-016-0168-y</pub-id><pub-id pub-id-type="pmcid">PMC5088662</pub-id></mixed-citation></ref><ref id="R13"><label>[13]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Black</surname><given-names>KC</given-names></name><name name-style="western"><surname>Luehmann</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Comparison study of gold nanohexapods, nanorods, and nanocages for photothermal cancer treatment</article-title>. <source>ACS Nano</source><year>2013</year>;<volume>7</volume>:<fpage>2068&#8211;77</fpage>.<pub-id pub-id-type="pmid">23383982</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/nn304332s</pub-id><pub-id pub-id-type="pmcid">PMC3609935</pub-id></mixed-citation></ref><ref id="R14"><label>[14]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoon</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Kim</surname><given-names>TH</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name><etal/></person-group>. <article-title>Sensitive capture of circulating tumour cells by functionalized graphene oxide nanosheets</article-title>. <source>Nat Nanotechnol</source><year>2013</year>;<volume>8</volume>:<fpage>735&#8211;41</fpage>.<pub-id pub-id-type="pmid">24077027</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nnano.2013.194</pub-id><pub-id pub-id-type="pmcid">PMC4017624</pub-id></mixed-citation></ref><ref id="R15"><label>[15]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Q</given-names></name><name name-style="western"><surname>Liang</surname><given-names>C</given-names></name><name name-style="western"><surname>Wang</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>An imagable and photothermal &#8220;Abraxane-like&#8221; nanodrug for combination cancer therapy to treat subcutaneous and metastatic breast tumors</article-title>. <source>Adv Mater</source><year>2015</year>;<volume>27</volume>:<fpage>903&#8211;10</fpage>.<pub-id pub-id-type="pmid">25504416</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/adma.201404308</pub-id></mixed-citation></ref><ref id="R16"><label>[16]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gavas</surname><given-names>S</given-names></name><name name-style="western"><surname>Quazi</surname><given-names>S</given-names></name><name name-style="western"><surname>Karpi&#324;ski</surname><given-names>TM</given-names></name></person-group>. <article-title>Nanoparticles for cancer therapy: current progress and challenges</article-title>. <source>Nanoscale Res Lett</source><year>2021</year>;<volume>16</volume>:<fpage>173</fpage>.<pub-id pub-id-type="pmid">34866166</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s11671-021-03628-6</pub-id><pub-id pub-id-type="pmcid">PMC8645667</pub-id></mixed-citation></ref><ref id="R17"><label>[17]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>X</given-names></name><name name-style="western"><surname>Wang</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Tunable photoluminescence of water-soluble AgInZnS&#8211;graphene oxide (GO) nanocomposites and their application in-vivo bioimaging</article-title>. <source>Sensors and Actuat B Chem</source><year>2017</year>;<volume>252</volume>:<fpage>1179</fpage>&#8211;<lpage>86</lpage>.</mixed-citation></ref><ref id="R18"><label>[18]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yao</surname><given-names>X</given-names></name><name name-style="western"><surname>Niu</surname><given-names>X</given-names></name><name name-style="western"><surname>Ma</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Graphene quantum dots-capped magnetic mesoporous silica nanoparticles as a multifunctional platform for controlled drug delivery, magnetic hyperthermia, and photothermal therapy</article-title>. <source>Small</source><year>2017</year>;<volume>13</volume>:<fpage>1602225</fpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/smll.201602225</pub-id><pub-id pub-id-type="pmid">27735129</pub-id></mixed-citation></ref><ref id="R19"><label>[19]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheng</surname><given-names>L</given-names></name><name name-style="western"><surname>Yang</surname><given-names>K</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Multifunctional nanoparticles for upconversion luminescence/MR multimodal imaging and magnetically targeted photothermal therapy</article-title>. <source>Biomaterials</source><year>2012</year>;<volume>33</volume>:<fpage>2215&#8211;22</fpage>.<pub-id pub-id-type="pmid">22169825</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.biomaterials.2011.11.069</pub-id></mixed-citation></ref><ref id="R20"><label>[20]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>K</given-names></name><name name-style="western"><surname>Feng</surname><given-names>L</given-names></name><name name-style="western"><surname>Shi</surname><given-names>X</given-names></name><etal/></person-group>. <article-title>Nano-graphene in biomedicine: theranostic applications</article-title>. <source>Chem Soc Rev</source><year>2013</year>;<volume>42</volume>:<fpage>530&#8211;47</fpage>.<pub-id pub-id-type="pmid">23059655</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1039/c2cs35342c</pub-id></mixed-citation></ref><ref id="R21"><label>[21]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Azimzadeh</surname><given-names>M</given-names></name><name name-style="western"><surname>Rahaie</surname><given-names>M</given-names></name><name name-style="western"><surname>Nasirizadeh</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>An electrochemical nanobiosensor for plasma miRNA-155, based on graphene oxide and gold nanorod, for early detection of breast cancer</article-title>. <source>Biosens Bioelectron</source><year>2016</year>;<volume>77</volume>:<fpage>99&#8211;106</fpage>.<pub-id pub-id-type="pmid">26397420</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bios.2015.09.020</pub-id></mixed-citation></ref><ref id="R22"><label>[22]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>K</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>S</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy</article-title>. <source>Nano Lett</source><year>2010</year>;<volume>10</volume>:<fpage>3318&#8211;23</fpage>.<pub-id pub-id-type="pmid">20684528</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/nl100996u</pub-id></mixed-citation></ref><ref id="R23"><label>[23]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Robinson</surname><given-names>JT</given-names></name><name name-style="western"><surname>Tabakman</surname><given-names>SM</given-names></name><name name-style="western"><surname>Liang</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Ultrasmall reduced graphene oxide with high near-infrared absorbance for photothermal therapy</article-title>. <source>J Am Chem Soc</source><year>2011</year>;<volume>133</volume>:<fpage>6825&#8211;31</fpage>.<pub-id pub-id-type="pmid">21476500</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/ja2010175</pub-id></mixed-citation></ref><ref id="R24"><label>[24]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>D</given-names></name><name name-style="western"><surname>Feng</surname><given-names>L</given-names></name><name name-style="western"><surname>Dougherty</surname><given-names>CA</given-names></name><etal/></person-group>. <article-title>In vivo targeting of metastatic breast cancer via tumor vasculature-specific nano-graphene oxide</article-title>. <source>Biomaterials</source><year>2016</year>;<volume>104</volume>:<fpage>361&#8211;71</fpage>.<pub-id pub-id-type="pmid">27490486</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.biomaterials.2016.07.029</pub-id><pub-id pub-id-type="pmcid">PMC5644339</pub-id></mixed-citation></ref><ref id="R25"><label>[25]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dreyer</surname><given-names>DR</given-names></name><name name-style="western"><surname>Park</surname><given-names>S</given-names></name><name name-style="western"><surname>Bielawski</surname><given-names>CW</given-names></name><etal/></person-group>. <article-title>The chemistry of graphene oxide</article-title>. <source>Chem Soc Rev</source><year>2010</year>;<volume>39</volume>:<fpage>228&#8211;40</fpage>.<pub-id pub-id-type="pmid">20023850</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1039/b917103g</pub-id></mixed-citation></ref><ref id="R26"><label>[26]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name><name name-style="western"><surname>Cui</surname><given-names>L</given-names></name><name name-style="western"><surname>Losic</surname><given-names>D</given-names></name></person-group>. <article-title>Graphene and graphene oxide as new nanocarriers for drug delivery applications</article-title>. <source>Acta Biomater</source><year>2013</year>;<volume>9</volume>:<fpage>9243&#8211;57</fpage>.<pub-id pub-id-type="pmid">23958782</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.actbio.2013.08.016</pub-id></mixed-citation></ref><ref id="R27"><label>[27]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yang</surname><given-names>ST</given-names></name><name name-style="western"><surname>Liu</surname><given-names>JH</given-names></name><etal/></person-group>. <article-title>In vitro toxicity evaluation of graphene oxide on A549 cells</article-title>. <source>Toxicol Lett</source><year>2011</year>;<volume>200</volume>:<fpage>201&#8211;10</fpage>.<pub-id pub-id-type="pmid">21130147</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.toxlet.2010.11.016</pub-id></mixed-citation></ref><ref id="R28"><label>[28]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yazdan</surname><given-names>M</given-names></name><name name-style="western"><surname>Naghib</surname><given-names>SM</given-names></name></person-group>, <person-group person-group-type="author"><name name-style="western"><surname>Mozafari</surname><given-names>MR</given-names></name></person-group>. <article-title>Polymeric micelle-based nanogels as emerging drug delivery systems in breast cancer treatment: promises and challenges</article-title>. <source>Curr Drug Targets</source><year>2024</year>;<volume>25</volume>:<fpage>649&#8211;69</fpage>.<pub-id pub-id-type="pmid">38919076</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2174/0113894501294136240610061328</pub-id></mixed-citation></ref><ref id="R29"><label>[29]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abbasi</surname><given-names>E</given-names></name><name name-style="western"><surname>Akbarzadeh</surname><given-names>A</given-names></name><name name-style="western"><surname>Kouhi</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Graphene: synthesis, bio-applications, and properties</article-title>. <source>Artif Cells Nanomed Biotechnol</source><year>2016</year>;<volume>44</volume>:<fpage>150&#8211;56</fpage>.<pub-id pub-id-type="pmid">24978443</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/21691401.2014.927880</pub-id></mixed-citation></ref><ref id="R30"><label>[30]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>L</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Z</given-names></name><etal/></person-group>. <article-title>Mechanisms of oxidative stress, apoptosis, and autophagy involved in graphene oxide nanomaterial anti-osteosarcoma effect</article-title>. <source>Int J Nanomed</source><year>2018</year>;<volume>13</volume>:<fpage>2907&#8211;19</fpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/IJN.S159388</pub-id><pub-id pub-id-type="pmcid">PMC5961647</pub-id><pub-id pub-id-type="pmid">29844673</pub-id></mixed-citation></ref><ref id="R31"><label>[31]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cui</surname><given-names>G</given-names></name><name name-style="western"><surname>Wu</surname><given-names>J</given-names></name><name name-style="western"><surname>Lin</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Graphene-based nanomaterials for breast cancer treatment: promising therapeutic strategies</article-title>. <source>J Nanobiotechnology</source><year>2021</year>;<volume>19</volume>:<fpage>211</fpage>.<pub-id pub-id-type="pmid">34266419</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12951-021-00902-8</pub-id><pub-id pub-id-type="pmcid">PMC8281664</pub-id></mixed-citation></ref><ref id="R32"><label>[32]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kersting</surname><given-names>D</given-names></name><name name-style="western"><surname>Fasbender</surname><given-names>S</given-names></name><name name-style="western"><surname>Pilch</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>From in vitro to ex vivo: subcellular localization and uptake of graphene quantum dots into solid tumors</article-title>. <source>Nanotechnology</source><year>2019</year>;<volume>30</volume>:<fpage>395101</fpage>.<pub-id pub-id-type="pmid">31239418</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1088/1361-6528/ab2cb4</pub-id></mixed-citation></ref><ref id="R33"><label>[33]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kadkhoda</surname><given-names>J</given-names></name><name name-style="western"><surname>Akrami-Hasan-Kohal</surname><given-names>M</given-names></name><name name-style="western"><surname>Tohidkia</surname><given-names>MR</given-names></name><etal/></person-group>. <article-title>Advances in antibody nanoconjugates for diagnosis and therapy: a review of recent studies and trends</article-title>. <source>Int J Biol Macromol</source><year>2021</year>;<volume>185</volume>:<fpage>664&#8211;78</fpage>.<pub-id pub-id-type="pmid">34224755</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ijbiomac.2021.06.191</pub-id></mixed-citation></ref><ref id="R34"><label>[34]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kadkhoda</surname><given-names>J</given-names></name><name name-style="western"><surname>Tarighatnia</surname><given-names>A</given-names></name><name name-style="western"><surname>Tohidkia</surname><given-names>MR</given-names></name><etal/></person-group>. <article-title>Photothermal therapy-mediated autophagy in breast cancer treatment: progress and trends</article-title>. <source>Life Sci</source><year>2022</year>;<volume>298</volume>:<fpage>120499</fpage>.<pub-id pub-id-type="pmid">35346674</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.lfs.2022.120499</pub-id></mixed-citation></ref><ref id="R35"><label>[35]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Bhattarai</surname><given-names>P</given-names></name><name name-style="western"><surname>Dai</surname><given-names>Z</given-names></name><etal/></person-group>. <article-title>Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer</article-title>. <source>Chem Soc Rev</source><year>2019</year>;<volume>48</volume>:<fpage>2053&#8211;108</fpage>.<pub-id pub-id-type="pmid">30259015</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1039/c8cs00618k</pub-id><pub-id pub-id-type="pmcid">PMC6437026</pub-id></mixed-citation></ref><ref id="R36"><label>[36]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Cong</surname><given-names>L</given-names></name><name name-style="western"><surname>He</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Photothermal treatment with EGFRmAb-AuNPs induces apoptosis in hypopharyngeal carcinoma cells via PI3K/AKT/mTOR and DNA damage response pathways</article-title>. <source>Acta Biochim Biophys Sin (Shanghai)</source><year>2018</year>;<volume>50</volume>:<fpage>567&#8211;78</fpage>.<pub-id pub-id-type="pmid">29718150</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/abbs/gmy046</pub-id></mixed-citation></ref><ref id="R37"><label>[37]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>HH</given-names></name><name name-style="western"><surname>Lin</surname><given-names>CH</given-names></name><name name-style="western"><surname>Chen</surname><given-names>YC</given-names></name><etal/></person-group>. <article-title>Dopamine-modified zero-valent iron nanoparticles for dual-modality photothermal and photodynamic breast cancer therapy</article-title>. <source>ChemMedChem</source><year>2020</year>;<volume>15</volume>:<fpage>1645&#8211;51</fpage>.<pub-id pub-id-type="pmid">32338431</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cmdc.202000192</pub-id></mixed-citation></ref><ref id="R38"><label>[38]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fisher</surname><given-names>JW</given-names></name><name name-style="western"><surname>Sarkar</surname><given-names>S</given-names></name><name name-style="western"><surname>Buchanan</surname><given-names>CF</given-names></name><etal/></person-group>. <article-title>Photothermal response of human and murine cancer cells to multiwalled carbon nanotubes after laser irradiation</article-title>. <source>Cancer Res</source><year>2010</year>;<volume>70</volume>:<fpage>9855&#8211;64</fpage>.<pub-id pub-id-type="pmid">21098701</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1158/0008-5472.CAN-10-0250</pub-id><pub-id pub-id-type="pmcid">PMC3699181</pub-id></mixed-citation></ref><ref id="R39"><label>[39]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name><name name-style="western"><surname>Ning</surname><given-names>C</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Z</given-names></name><etal/></person-group>. <article-title>Nanomaterials as photothermal therapeutic agents</article-title>. <source>Prog Mater Sci</source><year>2019</year>;<volume>99</volume>:<fpage>1&#8211;26</fpage>.<pub-id pub-id-type="pmid">30568319</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.pmatsci.2018.07.005</pub-id><pub-id pub-id-type="pmcid">PMC6295417</pub-id></mixed-citation></ref><ref id="R40"><label>[40]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hashemi</surname><given-names>M</given-names></name><name name-style="western"><surname>Omidi</surname><given-names>M</given-names></name><name name-style="western"><surname>Muralidharan</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>Evaluation of the photothermal properties of a reduced graphene oxide/arginine nanostructure for near-infrared absorption</article-title>. <source>ACS Appl Mater Interfaces</source><year>2017</year>;<volume>9</volume>:<fpage>32607&#8211;20</fpage>.<pub-id pub-id-type="pmid">28841283</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acsami.7b11291</pub-id></mixed-citation></ref><ref id="R41"><label>[41]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nergiz</surname><given-names>SZ</given-names></name><name name-style="western"><surname>Gandra</surname><given-names>N</given-names></name><name name-style="western"><surname>Tadepalli</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Multifunctional hybrid nanopatches of graphene oxide and gold nanostars for ultraefficient photothermal cancer therapy</article-title>. <source>ACS Appl Mater Interfaces</source><year>2014</year>;<volume>6</volume>:<fpage>16395&#8211;402</fpage>.<pub-id pub-id-type="pmid">25152960</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/am504795d</pub-id></mixed-citation></ref><ref id="R42"><label>[42]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jafarirad</surname><given-names>S</given-names></name><name name-style="western"><surname>Hammami Torghabe</surname><given-names>E</given-names></name><name name-style="western"><surname>Rasta</surname><given-names>SH</given-names></name><etal/></person-group>. <article-title>A novel non-invasive strategy for low-level laser-induced cancer therapy by using new Ag/ZnO and Nd/ZnO functionalized reduced graphene oxide nanocomposites</article-title>. <source>Artif Cells Nanomed Biotechnol</source><year>2018</year>;<volume>46</volume>:<fpage>800&#8211;16</fpage>.<pub-id pub-id-type="pmid">29764213</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/21691401.2018.1470523</pub-id></mixed-citation></ref><ref id="R43"><label>[43]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>X</given-names></name><name name-style="western"><surname>Lei</surname><given-names>J</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Two-dimensional graphene nanomaterials for combined photothermal and chemotherapy-enhanced targeted therapy of breast cancer</article-title>. <source>Mater Today Bio</source><year>2025</year>;<volume>32</volume>:<fpage>101668</fpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.mtbio.2025.101668</pub-id><pub-id pub-id-type="pmcid">PMC11957798</pub-id><pub-id pub-id-type="pmid">40166381</pub-id></mixed-citation></ref><ref id="R44"><label>[44]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>M</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>G</given-names></name><name name-style="western"><surname>Hou</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>4D printed stimuli responsive scaffold with tissue expansion and photothermal tumor ablation property for post-mastectomy breast reconstruction</article-title>. <source>Adv Healthc Mater</source><year>2025</year>;<volume>14</volume>:<fpage>e2404575</fpage>.<pub-id pub-id-type="pmid">40095339</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/adhm.202404575</pub-id></mixed-citation></ref><ref id="R45"><label>[45]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Q</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hu</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Local exosome inhibition potentiates mild photothermal immunotherapy against breast cancer</article-title>. <source>Adv Sci (Weinh)</source><year>2025</year>;<volume>12</volume>:<fpage>e2406328</fpage>.<pub-id pub-id-type="pmid">39574346</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/advs.202406328</pub-id><pub-id pub-id-type="pmcid">PMC11727390</pub-id></mixed-citation></ref><ref id="R46"><label>[46]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Itoo</surname><given-names>AM</given-names></name><name name-style="western"><surname>Paul</surname><given-names>M</given-names></name><name name-style="western"><surname>Jain</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>Biotinylated platinum(IV)-conjugated graphene oxide nanoparticles for targeted chemo-photothermal combination therapy in breast cancer</article-title>. <source>Biomater Adv</source><year>2025</year>;<volume>168</volume>:<fpage>214121</fpage>.<pub-id pub-id-type="pmid">39577365</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bioadv.2024.214121</pub-id></mixed-citation></ref><ref id="R47"><label>[47]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rahimzadeh</surname><given-names>Z</given-names></name><name name-style="western"><surname>Naghib</surname><given-names>S</given-names></name><name name-style="western"><surname>Askari</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>A rapid nanobiosensing platform based on herceptin-conjugated graphene for ultrasensitive detection of circulating tumor cells in early breast cancer</article-title>. <source>Nanotechnol Rev</source><year>2021</year>;<volume>10</volume>:<fpage>744&#8211;53</fpage>.</mixed-citation></ref><ref id="R48"><label>[48]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>S</given-names></name><name name-style="western"><surname>Ahn</surname><given-names>S</given-names></name><name name-style="western"><surname>Kim</surname><given-names>JY</given-names></name><etal/></person-group>. <article-title>Blood test for breast cancer screening through the detection of tumor-associated circulating transcripts</article-title>. <source>Int J Mol Sci</source><year>2022</year>;<volume>23</volume>:<fpage>9140</fpage>.<pub-id pub-id-type="pmid">36012405</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms23169140</pub-id><pub-id pub-id-type="pmcid">PMC9409068</pub-id></mixed-citation></ref><ref id="R49"><label>[49]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>C</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Local extraction and detection of early stage breast cancers through a microneedle and nano-Ag/MBL film based painless and blood-free strategy</article-title>. <source>Mater Sci Eng C Mater Biol Appl</source><year>2020</year>;<volume>109</volume>:<fpage>110402</fpage>.<pub-id pub-id-type="pmid">32228911</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.msec.2019.110402</pub-id></mixed-citation></ref><ref id="R50"><label>[50]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mittal</surname><given-names>S</given-names></name><name name-style="western"><surname>Kaur</surname><given-names>H</given-names></name><name name-style="western"><surname>Gautam</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>Biosensors for breast cancer diagnosis: a review of bioreceptors, biotransducers and signal amplification strategies</article-title>. <source>Biosens Bioelectron</source><year>2017</year>;<volume>88</volume>:<fpage>217&#8211;31</fpage>.<pub-id pub-id-type="pmid">27567264</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bios.2016.08.028</pub-id></mixed-citation></ref><ref id="R51"><label>[51]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Henry</surname><given-names>NL</given-names></name><name name-style="western"><surname>Braun</surname><given-names>TM</given-names></name><name name-style="western"><surname>Breslin</surname><given-names>TM</given-names></name><etal/></person-group>. <article-title>Variation in the use of advanced imaging at the time of breast cancer diagnosis in a statewide registry</article-title>. <source>Cancer</source><year>2017</year>;<volume>123</volume>:<fpage>2975&#8211;83</fpage>.<pub-id pub-id-type="pmid">28301680</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cncr.30674</pub-id></mixed-citation></ref><ref id="R52"><label>[52]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mazloum-Ardakani</surname><given-names>M</given-names></name><name name-style="western"><surname>Tavakolian-Ardakani</surname><given-names>Z</given-names></name><name name-style="western"><surname>Sahraei</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>Fabrication of an ultrasensitive and selective electrochemical aptasensor to detect carcinoembryonic antigen by using a new nanocomposite</article-title>. <source>Biosens Bioelectron</source><year>2019</year>;<volume>129</volume>:<fpage>1&#8211;6</fpage>.<pub-id pub-id-type="pmid">30677696</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bios.2018.12.047</pub-id></mixed-citation></ref><ref id="R53"><label>[53]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mohammadpour-Haratbar</surname><given-names>A</given-names></name><name name-style="western"><surname>Zare</surname><given-names>Y</given-names></name><name name-style="western"><surname>Rhee</surname><given-names>KY</given-names></name></person-group>. <article-title>Electrochemical biosensors based on polymer nanocomposites for detecting breast cancer: recent progress and future prospects</article-title>. <source>Adv Colloid Interface Sci</source><year>2022</year>;<volume>309</volume>:<fpage>102795</fpage>.<pub-id pub-id-type="pmid">36242876</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cis.2022.102795</pub-id></mixed-citation></ref><ref id="R54"><label>[54]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khodaie</surname><given-names>A</given-names></name><name name-style="western"><surname>Heidarzadeh</surname><given-names>H</given-names></name></person-group>. <article-title>Ultra-sensitive surface plasmon resonance sensor integrating MXene (Ti3C2TX) and graphene for advanced carcinoembryonic antigen detection</article-title>. <source>Sci Rep</source><year>2025</year>;<volume>15</volume>:<fpage>13571</fpage>.<pub-id pub-id-type="pmid">40253475</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-025-97853-z</pub-id><pub-id pub-id-type="pmcid">PMC12009283</pub-id></mixed-citation></ref><ref id="R55"><label>[55]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>M</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>An ultrasensitive flexible biosensor enabled by high-performance graphene field-effect transistors with defect-free van der Waals contacts for breast cancer miRNA fast detection</article-title>. <source>Talanta</source><year>2025</year>;<volume>287</volume>:<fpage>127637</fpage>.<pub-id pub-id-type="pmid">39889678</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.talanta.2025.127637</pub-id></mixed-citation></ref><ref id="R56"><label>[56]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>X</given-names></name><name name-style="western"><surname>Cao</surname><given-names>S</given-names></name><name name-style="western"><surname>Deng</surname><given-names>X</given-names></name><etal/></person-group>. <article-title>Enhancing early breast cancer detection with APE1-triggered oligonucleotide probes and graphene oxide: the impact of variable AP site modification on sensitivity and specificity</article-title>. <source>Talanta</source><year>2025</year>;<volume>287</volume>:<fpage>127505</fpage>.<pub-id pub-id-type="pmid">39862516</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.talanta.2024.127505</pub-id></mixed-citation></ref><ref id="R57"><label>[57]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Garc&#237;a-Fern&#225;ndez</surname><given-names>D</given-names></name><name name-style="western"><surname>Guti&#233;rrez-G&#225;lvez</surname><given-names>L</given-names></name><name name-style="western"><surname>L&#243;pez-Diego</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>Tetrahedral DNA nanostructures, graphene and carbon nanodots-based electrochemiluminescent biosensor for BRCA1 gene mutation detection</article-title>. <source>Talanta</source><year>2025</year>;<volume>284</volume>:<fpage>127182</fpage>.<pub-id pub-id-type="pmid">39577381</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.talanta.2024.127182</pub-id></mixed-citation></ref><ref id="R58"><label>[58]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>Z</given-names></name><name name-style="western"><surname>Jin</surname><given-names>S</given-names></name><name name-style="western"><surname>Yang</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Luminol/PtCo@rGO and Au@CNTs-based electrochemiluminescence cytosensor for ultrasensitive detection of breast cancer CTCs</article-title>. <source>Anal Chim Acta</source><year>2025</year>;<volume>1335</volume>:<fpage>343452</fpage>.<pub-id pub-id-type="pmid">39643306</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.aca.2024.343452</pub-id></mixed-citation></ref><ref id="R59"><label>[59]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Parihar</surname><given-names>A</given-names></name><name name-style="western"><surname>Vishwakarma</surname><given-names>P</given-names></name><name name-style="western"><surname>Prajapati</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Non-invasive ultra-sensitive detection of breast cancer biomarker using cerium nanoparticle functionalized graphene oxide enabled impedimetric aptasensor</article-title>. <source>Biosens Bioelectron</source><year>2025</year>;<volume>268</volume>:<fpage>116925</fpage>.<pub-id pub-id-type="pmid">39541781</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bios.2024.116925</pub-id></mixed-citation></ref><ref id="R60"><label>[60]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>H</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Li</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Fabrication of graphene and AuNP core polyaniline shell nanocomposites as multifunctional theranostic platforms for SERS real-time monitoring and chemo-photothermal therapy</article-title>. <source>Theranostics</source><year>2016</year>;<volume>6</volume>:<fpage>1096&#8211;104</fpage>.<pub-id pub-id-type="pmid">27279904</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7150/thno.14361</pub-id><pub-id pub-id-type="pmcid">PMC4893638</pub-id></mixed-citation></ref><ref id="R61"><label>[61]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kumawat</surname><given-names>MK</given-names></name><name name-style="western"><surname>Thakur</surname><given-names>M</given-names></name><name name-style="western"><surname>Bahadur</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Preparation of graphene oxide-graphene quantum dots hybrid and its application in cancer theranostics</article-title>. <source>Mater Sci Eng C Mater Biol Appl</source><year>2019</year>;<volume>103</volume>:<fpage>109774</fpage>.<pub-id pub-id-type="pmid">31349528</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.msec.2019.109774</pub-id></mixed-citation></ref><ref id="R62"><label>[62]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reza</surname><given-names>KK</given-names></name><name name-style="western"><surname>Dey</surname><given-names>S</given-names></name><name name-style="western"><surname>Wuethrich</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Parallel profiling of cancer cells and proteins using a graphene oxide functionalized ac-EHD SERS immunoassay</article-title>. <source>Nanoscale</source><year>2018</year>;<volume>10</volume>:<fpage>18482&#8211;91</fpage>.<pub-id pub-id-type="pmid">30168562</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1039/c8nr02886a</pub-id></mixed-citation></ref><ref id="R63"><label>[63]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>L</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Eco-friendly development of an ultrasmall IONP-loaded nanoplatform for bimodal imaging-guided cancer theranostics</article-title>. <source>Biomater Sci</source><year>2020</year>;<volume>8</volume>:<fpage>6375&#8211;86</fpage>.<pub-id pub-id-type="pmid">33026363</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1039/d0bm00867b</pub-id></mixed-citation></ref><ref id="R64"><label>[64]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gholivand</surname><given-names>K</given-names></name><name name-style="western"><surname>Faraghi</surname><given-names>M</given-names></name><name name-style="western"><surname>Pooyan</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Anti-cancer activity of new phosphoramide-functionalized graphene oxides: an experimental and theoretical evaluation</article-title>. <source>Curr Med Chem</source><year>2023</year>;<volume>30</volume>:<fpage>3486&#8211;503</fpage>.<pub-id pub-id-type="pmid">36305155</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2174/0929867330666221027152716</pub-id></mixed-citation></ref><ref id="R65"><label>[65]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dolatkhah</surname><given-names>M</given-names></name><name name-style="western"><surname>Hashemzadeh</surname><given-names>N</given-names></name><name name-style="western"><surname>Barar</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Graphene-based multifunctional nanosystems for simultaneous detection and treatment of breast cancer</article-title>. <source>Colloids Surf B Biointerfaces</source><year>2020</year>;<volume>193</volume>:<fpage>111104</fpage>.<pub-id pub-id-type="pmid">32417466</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.colsurfb.2020.111104</pub-id></mixed-citation></ref><ref id="R66"><label>[66]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saroj</surname><given-names>S</given-names></name><name name-style="western"><surname>Us</surname><given-names>P</given-names></name><name name-style="western"><surname>Patil</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Herb extracellular vesicle-chitosan-pegylated graphene oxide conjugate delivers estrogen receptor &#945; targeting siRNA to breast cancer cells</article-title>. <source>ACS Appl Bio Mater</source><year>2024</year>;<volume>7</volume>:<fpage>2741&#8211;51</fpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acsabm.3c01108</pub-id><pub-id pub-id-type="pmid">38630629</pub-id></mixed-citation></ref><ref id="R67"><label>[67]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Yan</surname><given-names>L</given-names></name><name name-style="western"><surname>Wei</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>PEG-GO@XN nanocomposite suppresses breast cancer metastasis via inhibition of mitochondrial oxidative phosphorylation and blockade of epithelial-to-mesenchymal transition</article-title>. <source>Eur J Pharmacol</source><year>2021</year>;<volume>895</volume>:<fpage>173866</fpage>.<pub-id pub-id-type="pmid">33454376</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ejphar.2021.173866</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>